Collection Finding Aid

Menu

Guide to the Ralph Snyderman (Personal) Papers, 1899-2006 (MC.0115)

Abstract

Contains the collected papers of Ralph Snyderman, Chancellor Emeritus of Duke University, James B. Duke Professor of Medicine, and Director of the Duke Center for Research on Personalized Health Care. Materials document Snyderman's professional appointments at both Duke University and Genentech, Inc., a biomedical technology firm in San Francisco, California. The papers consist of publications, manuscript materials, research materials, collected publications and citations, presentations and related correspondence, travel files, Genentech, Inc. research and administrative materials, subject files, business records from Snyderman's role as Duke's Chancellor for Health Affairs, Association of American Medical Colleges (AAMC) committee and working group files, and papers from other committees and professional organizations of which Snyderman was a member. Major subjects in this collection include Snyderman's research in inflammation, immunology, and rheumatology; health care reform; medical administration and the role of the academic health center; and integrative and prospective medicine. Materials range in date from 1899 to 2006.

Descriptive Summary

Call Number
MC.0115
Title
Ralph Snyderman (Personal) Papers
Date
1899-2006
Creator
Snyderman, Ralph.
Extent
57.5 Linear Feet (38 cartons, 1 flat box)
Repository
Duke University Medical Center Archives

Collection Overview

Contains the collected papers of Ralph Snyderman. Materials document Snyderman's professional appointments at both Duke University and Genentech, Inc., a biomedical technology firm in San Francisco, California. The papers consist of publications, manuscript materials, research materials, collected publications and citations, presentations and related correspondence, travel files, Genentech, Inc. research and administrative materials, subject files, business records from Snyderman's role as Duke's Chancellor for Health Affairs, Association of American Medical Colleges (AAMC) committee and working group files, and papers from other committees and professional organizations of which Snyderman was a member. Major subjects include Snyderman's research in inflammation, immunology, and rheumatology; health care reform; medical administration and the role of the academic health center; and integrative and prospective medicine. Materials range in date from 1899 to 2006.

Arrangement Note

Organized into the following series: Writings and Publications, 1968-2002; Research, 1899-1989; Professional Papers, 1985-2005; Presentations and Talks, 1988-2003; Travel Files, 1983-2006; Genentech, 1985-1989; Personal/Biographical, 1971-1989; Subject Files, 1969-2000; Slides, circa 1977-1985.

Restrictions on Access & Use

Some collections are stored off site and must be requested at least 48 business hours in advance for retrieval.

Access Restrictions

This collection may contain materials with sensitive or confidential information that is protected under federal or state right to privacy laws and regulations, including the Health Insurance Portability and Accountability Act (HIPAA). Researchers are advised that the disclosure of certain information pertaining to identifiable individuals represented in this collection without the consent of those individuals or IRB approval may have legal ramifications (e.g., a cause of action under common law for invasion of privacy may arise if facts concerning an individual's private life are published that would be deemed highly offensive to a reasonable person) for which Duke University assumes no responsibility.

Contains Medical Center Administrative records. These include records of the officers of the University, as defined in the Bylaws, the deans of schools and colleges, and departments, institutes, and other offices as designated by the President. For a period of twenty-five years from the origin of the material, permission in writing from the director of the office of record and the Medical Center Archivist is required for use. After twenty-five years, records that have been processed may be consulted with the permission of the Medical Center Archivist. (Issued by the Office of the Chancellor, December 1, 1975).

Contains Records of the Board of Trustees of the Duke University Medical Center. These include minutes and supporting documentation of the Board, its Executive Committee, standing and ad hoc committees, reports, studies, and the like presented solely to the Board. Records which have been existence for at least fifty years are available for scholarly research with the permission of the Medical Center Archivist. Access to records which have been in existence for less than fifty years shall be granted only by special permission, in writing, of the Medical Center Board of Trustees.

Materials in boxes 36-38 are restricted and can only be accessed with the permission of the Medical Center Archivist.

Use Restrictions

Copyright for Official University records is held by Duke University; all other copyright is retained by the authors of items in these papers, or their descendants, as stipulated by United States copyright law.

Contents of the Collection

1. Writings and Publications, 1968-2002

Series Scope and Contents: Contains manuscript materials for Snyderman's publications; correspondence to and from editors, reviewers, and co-authors; photocopies and reprints of Snyderman's published writings; manuscripts written by others; and a list of Snyderman's publications with accompanying numbered reprints. Major subjects represented in the writings include findings from medical research, health care, and the role of the academic health center. Materials date from 1968 to 2002.

Publication Listing, 1968-2000

Subseries Scope and Contents: Contains a series of numbered reprints and photocopies of Snyderman's publications arranged in chronological order and accompanied by a numbered publications list. The materials in this subseries were received numbered and in chronological order. The numbering system may possibly correspond to a CV list of publications. The bulk of the materials are reprints or photocopies of articles. Some publications contain corresponding manuscript materials such as drafts, correspondence, and page proofs, which have been retained in this subseries to reflect original arrangement and order. Materials date from 1968 to 2000.

Processing Information: The folder for publication 241, "Inhibition of Lymphocyte Proliferation by a Synthetic Peptide Homologous to Envelope Proteins and Human and Animal Retroviruses," arrived empty. As such, it is not listed in the finding aid container list, and the publication numbers skip from publication 240 to publication 242.

Publications List, 1986-1975, undated
Box 1
Publication 1. "Interactions of the Complement System with Endotoxic Lipopolysaccharide", 1968
Box 1
Publication 2. "Chemotactic and Anaphylatoxic Fragment Cleaved from the Fifth Component of Guinea Pig Complement", 1968
Box 1
Publication 3. "Decreased C'1q Protein Concentration and Agglutinating Activity in Agammaglobulinaemia Syndromes", 1968
Box 1
Publication 4. "Chemotactic Activity, a Property of Guinea Pig C'5-Anaphylatoxin", 1969
Box 1
Publication 5. "Decreased Properdin Activity in Acute Glomerulonephritis", 1969
Box 1
Publication 6. "Significance of Complement of the Mechanism of Action of Endotoxin", 1969
Box 1
Publication 7. "Reaction of a Cobra Venom Factor with Guinea Pig Complement and Generation of an Activity Chemotactic for Polymorphonuclear Leukocytes", 1969
Box 1
Publication 8. "A Neutrophil Chemotactic Factor Derived from C'5 upon Interaction of Guinea Pig Serum with Endotoxin", 1969
Box 1
Publication 9. "Interactions of the Complement System with Endotoxic Lipopolysaccharides", 1969
Box 1
Publication 10. "Neutralization of Sensitized Virus by the Fourth Component of Complement", 1969
Box 1
Publication 11. "Factors from Saliva and Oral Bacteria, Chemotactic for Polymorphonuclear Leukocytes", 1970
Box 1
Publication 12. "Immunologic Reactions and Periodontal Inflammation", 1970
Box 1
Publication 13. "Neutralization of Sensitized Virus by Purified Components of Complement", 1970
Box 1
Publication 14. "Polymorphonuclear Leukocyte Chemotactic Activity in Rabbit Serum and Guinea Pig Serum Treated with Immune Complexes", 1970
Box 1
Publication 15. "Interactions of the Complement System with Endotoxic Lipopolysaccharides in Immunoglobulin-Deficient Sera", 1970
Box 1
Publication 16. "Consumption of Hamster Complement by Bacterial Endotoxin", 1970
Box 1
Publication 17. "Histamine-Releasing Factor Generated by the Interaction of Endotoxin with Hamster Serum", 1970
Box 1
Publication 18. "Inflammation and Herpes Simplex Virus: Release of a Chemotaxis-Generating Factor from Infected Cells", 1970
Box 1
Publication 19. "Chemotaxis of Inflammatory Cells", 1971
Box 1
Publication 20. "Immune Fever in the Rabbit: Responses of the Hematologic and Complement Systems", 1971
Box 1
Publication 21. "The Relationship of Complement Consumption to Immune Fever", 1971
Box 1
Publication 22. "Effect of C4 Depletion on the Utilization of the Terminal Components of Guinea-pig Complement by Endotoxin", 1971
Box 1
Publication 23. "Periodontal Disease: A Model for the Study of Inflammation", 1971
Box 1
Publication 24. "Intrinsic Defect of the Polymorphonuclear Leucocyte Resulting in Impaired Chemotaxis and Phagocytosis", 1971
Box 1
Publication 25. "A Chemotactic Factor for Mononuclear Leukocytes", 1971
Box 1
Publication 26. "Biological Activity of Complement in Vivo", 1971
Box 1
Publication 27. "Effects of Endotoxic Lipopolysaccharides on the Complement System", 1971
Box 1
Publication 28. "Characterization of Polymorphonuclear Leukocyte Activity in Serums Activated by Various Inflammatory Agents", 1972
Box 1
Publication 29. "Role for Endotoxin and Complement in Periodontal Tissue Destruction", 1972
Box 1
Publication 30. "Humoral Mediators of Chemotaxis of Mononuclear Leukocytes", 1972
Box 1
Publication 31. "Production of Chemotactic Activity by Guinea Pig Immunoglobulins Following Activation of the C3 Complement Shunt Pathway", 1972
Box 1
Publication 32. "Human Mononuclear Leukocyte Chemotaxis: A Quantitative Assay for Humoral and Cellular Chemotactic Factors", 1972
Box 1
Publication 33. "Inflammation and Viral Infection", 1972
Box 1
Publication 34. "Activation of Complement by Endotoxin", 1972
Box 1
Publication 35. "Macrophage Proteinase and Inflammation", 1972
Box 1
Publication 36. "Bone Marrow-Derived Lymphoid Cells (B Cells): Functional Depletion with Cobra Factor and Fresh Serum", 1972
Box 1
Publication 37. "Further Characterization of a Factor From Endotoxin-Treated Serum Which Releases Histamine and Heparin from Mast Cells", 1972
Box 1
Publication 38. "Complement-Mediated Vasoconstriction and Graft Rejection", 1972
Box 1
Publication 39. "A Human Mononuclear Leukocyte Chemotactic Factor", 1973
Box 1
Publication 40. "Defective Mononuclear Leukocyte Chemotaxis", 1973
Box 1
Publication 41. "Humoral and Bacterial Mediators of Inflammation", 1973
Box 1
Publication 42. "Generation of Chemotactic Activity by Immune Complexes Carrying Clustered or Nonclustered C42 Sites", 1973
Box 1
Publication 43. "Depression of Lymphocyte Transformation and Exacerbation of Behcet's Syndrome by Ingestion of English Walnuts", 1973
Box 1
Publication 44. "Human Mononuclear Leukocyte Chemotaxis: Definition of Two Chemotactic Factors and a Previously Unrecognized Immune Dysfunction", 1973
Box 1
Publication 45. "Chemotaxis of Mononuclear Leukocytes", 1973
Box 1
Publication 46. "Cytogenetic Engineering In Vivo: Restoration of Biologic Complement Activity to C5-Deficient Mice by Intravenous Inoculation of Hybrid Cells", 1973
Box 1
Publication 47. "Mediators of Delayed Hypersensitivity", 1973
Box 1
Publication 48. "Activation of Complement by Endotoxin", 1973
Box 1
Publication 49. "Periodontal Disease Research: Introductory Remarks", 1973
Box 1
Publication 50. "The Role of the Immune Response in the Development of Periodontal Disease", 1973
Box 1
Publication 51. "Abnormalities of Chemotactic Lymphokine Synthesis and Mononuclear Leukocyte Chemotaxis in Wiskott-Aldrich Syndrome", 1974
Box 1
Publication 52. "Production of Chemotactic Factor and Lymphotoxin by Human Leukocytes Stimulated with Herpes Simplex Virus", 1974
Box 1
Publication 53. "Depression of Human Monocyte Chemotaxis by Herpes Simplex and Influenza Viruses", 1974
Box 1
Publication 54. "Defective Immune Effector Function in Patients with Neoplastic and Immune Deficiency Diseases", 1975
Box 1
Publication 55. "Characterization of Chemotactic Activity Produced In Vivo by a Cell-Mediated Immune Reaction in the Guinea Pig", 1975
Box 1
Publication 56. "Interaction of Complex Polysaccharides with the Complement System", 1975
Box 1
Publication 57. "Quantification of Mouse Macrophage Chemotaxis In Vitro: Role of C5 for the Production of Chemotactic Activity", 1975
Box 1
Publication 58. "Disorders of Human Leukocyte Chemotaxis", 1975
Box 1
Publication 59. "Abnormalities of Leukocyte Chemotaxis in Human Disease, 1975
Box 1
Publication 60. "Depressed Monocyte Chemotaxis During Acute Influenza Infection", 1975
Box 1
Publication 61. "Defective Monocyte Function in Patients with Genitourinary Carcinoma", 1975
Box 1
Publication 62. "Human Lymphocyte Motility: Normal Characteristics and Anomalous Behavior of Chronic Lymphocytic Leukemia Cells", 1976
Box 1
Publication 63. "Identification of [beta]-Adrenergic Receptors in Human Lymphocytes by (--)[3H]Alprenolol Binding", 1976
Box 1
Publication 64. "Chemotaxis of Macrophages", 1976
Box 1
Publication 65. "The Role of Lymphokines in Delayed Hypersensitivity Reactions", 1976
Box 1
Publication 66. "Effects of Neoplasms on Inflammation: Depression of Macrophage Accumulation after Tumor Implantation", 1976
Box 1
Publication 67. "An Inhibitor of Macrophage Chemotaxis Produced by Neoplasms", 1976
Box 1
Publication 68. "Augmentation of Human Monocyte Chemotactic Response by Levamisole", 1976
Box 1
Publication 69. "Autodestructive Immune Reactions Initiated by Antibody", 1976
Box 1
Publication 70. "Inflammation and the Complement System", 1976
Box 1
Publication 71. "Defective Macrophage Migration Produced by Neoplasms: Identification of an Inhibitor of Macrophage Chemotaxis", 1976
Box 1
Publication 72. "Chemotaxis of Mononuclear Cells", 1976
Box 1
Publication 73. "A Role for Adenosine Deaminase in Human Monocyte Maturation", 1976
Box 1
Publication 74. "Calcium Influx Requirement for Human Neutrophil Chemotaxis: Inhibition by Lanthanum Chloride", 1976
Box 1
Publication 75. "Depression of Macrophage Function by a Factor Produced by Neoplasms", 1976
Box 1
Publication 76. "Effect of Virus Infection on the Inflammatory Response", 1976
Box 1
Publication 77. "Prostaglandins and Inflammation: Enhancement of Monocyte Chemotactic Responsiveness by Prostaglandin E2", 1976
Box 1
Publication 78. "The Chemotactic Attraction of Human Fibroblasts to a Lymphocyte-Derived Factor", 1976
Box 1
Publication 79. "Biologic Aspects of Leukocyte Chemotaxis", 1977
Box 1
Publication 80. "The Role of Cell-Mediated Immunity in Atopic Diseases", 1977
Box 1
Publication 81. "Abnormalities of Monocyte Chemotaxis in Patients with Melanoma: Effects of Immunotherapy and Tumor Removal", 1977
Box 1
Publication 82. "Generalized Microsporum Audouinii Infection and Depressed Cellular Immunity Associated with a Missing Plasma Factor Required for Lymphocyte Blastogenesis", 1977
Box 1
Publication 83. "Characterization of Human Chemotactic Lymphokine Production Induced by Mitogens and Mixed Leukocyte Reactions Using a New Microassay", 1977
Box 1
Publication 84. "Specific Receptor Sites for Chemotactic Peptides on Human Polymorphonuclear Leukocytes", 1977
Box 1
Publication 85. "Influenza-Induced Depression of Monocyte Chemotaxis: Reversal by Levamisole", 1977
Box 1
Publication 86. "Disorders of Leukocyte Chemotaxis", 1977
Box 1
Publication 87. "Abnormalities of Leukotaxis in Atopic Dermatitis", 1977
Box 1
Publication 88. "Macrophage Migratory Dysfunction in Cancer", 1977
Box 1
Publication 89. "Cellular Serine Proteinase Induces Chemotaxis by Complement Activation", 1977
Box 1
Publication 90. "Biologic and Biochemical Activities of Continuous Macrophage Cell Lines P388D1 and J774.1", 1977
Box 1
Publication 91. "The Inflammatory Response and Resistance to Endotoxin in Mice", 1978
Box 1
Publication 92. "Chemotaxis and the Complement System", 1978
Box 1
Publication 93. "Clinical Usefulness of Hemolytic Complement Determination", 1978
Box 1
Publication 94. "Pathophysiologic Aspects of Leukocyte Chemotaxis", 1978
Box 1
Publication 95. "Levamisole and Human Monocyte Chemotaxis: Reversal of an Influenzal-Induced Chemotactic Defect", 1978
Box 1
Publication 96. "Abnormal Monocyte Chemotaxis in Patients with Breast Cancer: Evidence for a Tumor-Mediated Effect", 1978
Box 1
Publication 97. "Methodology for Monocyte and Macrophage Chemotaxis", 1978
Box 1
Publication 98. "Abortive and Productive Infections of Human Mononuclear Phagocytes by Type I Herpes Simplex Virus", 1978
Box 1
Publication 99. "Familial Deficiency of the Seventh Component of Complement Associated with Recurrent Bacteremic Infection Due to Neisseria", 1978
Box 1
Publication 100. "Requirement of S-adenosyl-L-methionine-Mediated Methylation for Human Monocyte Chemotaxis", 1978
Box 1
Publication 101. "The Role of Macrophages in the Rheumatic Diseases", 1978
Box 1
Publication 102. "Familial Deficiencies of the Sixth and Seventh Components of Complement Associated with Bacteremic Neisseria Infections", 1978
Box 1
Publication 103. "Resistance of Neoplasms to Immunological Destruction: Role of a Macrophage Chemotaxis Inhibitor", 1978
Box 1
Publication 104. "Quantification of Lymphokine Production in Human Disease", 1979
Box 1
Publication 105. "Biological Activities of a Macrophage Chemotaxis Inhibitor (MCI) Produced by Neoplasms", 1979
Box 1
Publication 106. "Hereditary C2 Deficiency Associated with Cutaneous Lupus Erythematosus", 1979
Box 1
Publication 107. "Neisseria Meningitidis and Neisseria Gonorrhoeae Bacteremia Associated with C6, C7, or C8 Deficiency", 1979
Box 1
Publication 108. "Rheumatoid Nodulosis: Sporadic and Familial Diseases", 1979
Box 1
Publication 109. "Do Macrophages Destory Nascent Tumors?", 1979
Box 1
Publication 110. "Stimulation of Neutrophil Oxidative Metabolism by Chemotactic Peptides", 1979
Box 1
Publication 111. "The 1978 Annual Meeting of the American Rheumatism Association", 1979
Box 1
Publication 112. "Neisseria Meningitidis Bacteremia in Association with Deficiency of the Sixth Component of Complement", 1979
Box 1
Publication 113. "Deficiency of the Fifth Component of Complement in Human Subjects", 1979
Box 1
Publication 114. "Further Studies of a Macrophage Chemotaxis Inhibitor (MCI) Produced by Neoplasms", 1979
Box 1
Publication 115. "Antibodies Raised Against Purified [beta]-adrenergic Receptors Specifically Bind [beta]-adrenergic Ligands", 1979
Box 1
Publication 116. "Requirement of Transmethylation Reactions for Eukaryotic Cell Chemotaxis", 1979
Box 1
Publication 117. "Phospholipid Methylation in Macrophages Is Inhibited by Chemotactic Factors", 1979
Box 1
Publication 118. "Viral Antigens as Targets for Leukemia Immunotherapy", 1979
Box 1
Publication 119. "Laboratory Testing in Rheumatic Diseases: Avoiding the Pitfalls", 1979
Box 1
Publication 120. "Laboratory Testing in Rheumatic Diseases: Current Perspectives", 1979
Box 1
Publication 121. "Generation of a Fibroblast Chemotactic Factor in Serum by Activation of Complement", 1979
Box 1
Publication 122. "The Complement System", 1979
Box 1
Publication 123. "Inflammation and Autodestructive Reactions Initiated by Antibody", 1979
Box 1
Publication 124. "Chronic Mucocutaneous Candidiasis", 1979
Box 1
Publication 125. "Role of Transmethylation Reactions in Cellular Motility and Phagocytosis", 1980
Box 1
Publication 126. "A Macrophage Chemotaxis Inhibitor Produced by Neoplasms: Characterization of its Biological Activity", 1980
Box 1
Publication 127. "Lipid Requirements for Leukocyte Chemotaxis and Phagocytosis", 1980
Box 1
Publication 128. "Genetic Control of Peripheral Leukocyte Response to Endotoxin in Mice", 1980
Box 1
Publication 129. "Absence of Macrophage Involvement in the Passive Serum Therapy of Friend Leukemia Virus-Induced Disease", 1980
Box 1
Publication 130. "An Inherited Abnormality of Neutrophil Adhesion", 1980
Box 1
Publication 131. "Demonstration of a Chemotactic Factor Receptor on Macrophages", 1980
Box 1
Publication 132. "Macrophage Accumulation in Mice Is Inhibited by Low Molecular Weight Products from Murine Leukemia Viruses", 1980
Box 1
Publication 133. "An Inhibitor of Macrophage Accumulation Producted by Neoplasms: Its Role in Abrogating Host Resistance to Cancer", 1980
Box 1
Publication 134. "Influence of Cytoskeletal Assembly on Phosphatidylcholine Synthesis in Intact Phagocytic Cells", 1980
Box 1
Publication 135. "Development of Specific Receptors for N-Formylated Chemotactic Peptides in a Human Monocyte Cell Line Stimulated with Lymphokines", 1980
Box 1
Publication 136. "Genetic Control of Leukocyte Responses to Endotoxic Lipopolysaccharides in Mice", 1980
Box 1
Publication 137. "Chemotactically Responsive and Nonresponsive Forms of a Continuous Human Monocyte Cell Line", 1980
Box 1
Publication 138. "N-Formylmethionyl Peptide Receptors on Equine Leukocytes Initiate Secretion but Not Chemotaxis", 1980
Box 1
Publication 139. "Cell Wars", 1980
Box 1
Publication 140. "Depression of Murine Macrophage Accumulation by Low-Molecular-Weight Factors Derived From Spontaneous Mammary Carcinomas", 1980
Box 1
Publication 141. "Biochemical and Biological Aspects of Leukocyte Chemotactic Factors", 1980
Box 1
Publication 142. "Monocyte Responsiveness to Chemotactic Stimuli Is a Property of a Subpopulation of Cells That Can Respond to Multiple Chemoattractants", 1981
Box 1
Publication 143. "Mechanisms of Nonspecific Host Resistance", 1981
Box 1
Publication 144. "Quantification of Macrophage Accumulation in Vivo", 1981
Box 1
Publication 145. "In Vitro Methods for the Study of Macrophage Chemotaxis", 1981
Box 1
Publication 146. "Quantification of Monocyte Function in Patients with Cancer: Evidence for a Tumor Mediated Dysfunction", 1981
Box 1
Publication 147. "Receptors and Transductional Events in Leukocyte Chemotaxis", 1981
Box 1
Publication 148. "Requirement of Transmethylation Reactions for Immune Effector Function", 1981
Box 1
Publication 149. "Differential Anti-Inflammatory Effects of LPS in Susceptible and Resistant Mouse Strains", 1981
Box 1
Publication 150. "The Role of Transmethylation Reactions in Regulating the Binding of BCG-Activated Murine Macrophages to Neoplastic Target Cells", 1981
Box 1
Publication 151. "Chemotactic Factor Receptors on Leukocytes", 1981
Box 1
Publication 152. "Molecular and Cellular Mechanisms of Leukocyte Chemotaxis", 1981
Box 1
Publication 153. "Transmethylation Reactions are Required for Initial Morphologic and Biochemical Responses of Human Monocytes to Chemoattractants", 1981
Box 1
Publication 154. "Alterations of New Methylated Phospholipid Synthesis in the Plasma Membranes of Macrophages Exposed to Chemoattractants", 1981
Box 1
Publication 155. "Immunology" Article, 1981
Box 1
Publication 156. "Inhibitors of Monocyte Responses to Chemotaxins Are Present in Human Cancerous Effusions and React with Monoclonal Antibodies to the P15(E) Structural Protein of Retroviruses, 1981
Box 1
Publication 157. "Specific Receptors and Transmethylation Reactions in Macrophages: A Model for Macrophage Chemotaxis", 1981
Box 1
Publication 158. "U937 Cell Line: A New Model for Studies of Human Monocytes", 1981
Box 1
Publication 159. "Characterization of an Inhibitor of Monocyte Function in Effusions of Cancer Patients", 1981
Box 1
Publication 160. "Disorders of Human Leukocyte Chemotaxis", 1981
Box 1
Publication 161. "Chemoattractant-Receptor Interactions in Leukocytes", 1982
Box 1
Publication 162. "Binding of Synthetic Chemotactic Peptides as a Model of Ligand-Receptor Interaction", 1982
Box 1
Publication 163. "Chemotaxis of Human and Murine Mononuclear Phagocytes", 1982
Box 1
Publication 164. "Quantitation of the Inflammatory Accumulation of Mononuclear Phagocytes in Vivo", 1982
Box 1
Publication 165. "Endotoxin (LPS) Stimulates In Vitro Migration of Macrophages from LPS-Resistant Mice but Not From LPS-Sensitive Mice", 1982
Box 1
Publication 166. "Transmethylation Reactions Regulate Affinity and Functional Activity of Chemotactic Factor Receptors on Macrophages", 1982
Box 1
Publication 167. "Clinical Implications of Host-Parasite Interactions", 1982
Box 1
Publication 168. "Cyclic Nucleotides Regulate the Morphologic Alterations Required for Chemotaxis in Monocytes", 1982
Box 1
Publication 169. "Induction of Cellular Immunity to Coccidioides Immitis After Sensitization with Dinitrochlorobenzene", 1982
Box 1
Publication 170. "Behcet's Disease", 1982
Box 1
Publication 171. "Mechanisms of Inflammation and Tissue Destruction in the Rheumatic Diseases", 1982
Box 1
Publication 172. "The Oligopeptide Chemotactic Factor Receptor on Human Polymorphonuclear Leukocyte Membranes Exists in Two Affinity States", 1982
Box 1
Publication 173. "Effects of Neoplasms on Mononuclear Phagocytes", 1982
Box 1
Publication 174. "Immunology", 1982
Box 1
Publication 175. "Specific Receptors and Transmethylation Reactions Are Required for Leukocyte Chemotaxis", 1982
Box 1
Publication 176. "Amphotericin B Alters the Affinity and Functional Activity of the Oligopeptide Chemotactic Factor Receptor on Human Polymorphonuclear Leukocytes", 1982
Box 1
Publication 177. "Chemoattractant Receptor Functions in Human Polymorphonuclear Leukocytes Are Divergently Altered by Membrane Fluidizers", 1982
Box 1
Publication 178. "Inhibitors of Monocyte Responses to Chemotaxins Are Associated with Human Neoplasms", 1982
Box 1
Publication 179. "Hormonal Activation of Adenylate Cyclase in Macrophage Membranes is Regulated by Guanine Nucleotides", 1983
Box 1
Publication 180. "Chemoattractant Receptor Affinity Reflects its Ability to Transduce Different Biological Responses", 1983
Box 1
Publication 181. "Methylation Reactions in the Regulation of Mononuclear Phagocyte Function", 1983
Box 1
Publication 182. "Activation of the Respiratory Burst Enzyme in Human Polymorphonuclear Leukocytes by Chemoattractants and Other Soluble Stimuli", 1983
Box 1
Publication 183. "Leukocyte Chemotaxis", 1983
Box 1
Publication 184. "Characterization of the Oligopeptide Chemoattractant Receptor on Leukocytes: Binding Affinity Reflects Signal Transduction", 1983
Box 1
Publication 185. "Murine Malignant Cells Synthesize a 19,000-Dalton Protein that is Physicochemically and Antigenically Related to the Immunosuppressive Retroviral Protein, P15E", 1983
Box 1
Publication 186. "Induction of Selective Biological Responses to Chemoattractants in a Human Monocyte-Like Cell Line", 1983
Box 1
Publication 187. "Neoplasia and Mononuclear Phagocyte Function", 1983
Box 1
Publication 188. "Guanine Nucleotides Modulate the Binding Affinity of the Oligopeptide Chemoattractant Receptor on Human Polymorphonuclear Leukocytes", 1983
Box 1
Publication 189. "Polymorphonuclear Leukocyte Function in Psoriasis: Chemotaxis, Chemokinesis, Beta-Adrenergic Receptors, and Proteolytic Enzymes of Polymorphonuclear Leukocytes in the Peripheral Blood from Psoriatic Patients", 1983
Box 1
Publication 190. "Pharmacologic Manipulation of Leukocyte Chemotaxis: Present Knowledge and Future Trends", 1983
Box 1
Publication 191. "Pharmacological Manipulation of the Chemotactic Factor Receptor on Leukocytes", 1983
Box 1
Publication 192. "Effect of Membrane Fluidizers on the Number and Affinity of Chemotactic Factor Receptors on Human Polymorphonuclear Leukocytes", 1983
Box 1
Publication 193. "A Chemoattractant Receptor on Macrophages Exists in Two Affinity States Regulated by Guanine Nucleotides", 1984
Box 1
Publication 194. "Transduction Mechanisms of a Leukocyte Chemoattractant Receptor", 1984
Box 1
Publication 195. "Human Malignant and Mitogen-Transformed Cells Contain Retroviral P15E-Related Antigen", 1984
Box 1
Publication 196. "Rapid Changes in Light Scattering from Human Polymorphonuclear Leukocytes Exposed to Chemoattractants", 1984
Box 1
Publication 197. "Mechanisms of Regulating the Respiratory Burst in Leukocytes", 1984
Box 1
Publication 198. "Immunopathology", 1984
Box 1
Publication 199. "The Complement System", 1984
Box 1
Publication 200. "A Potential Second Messenger Role for Unsaturated Fatty Acids: Activation of Ca2+-Dependent Protein Kinase", 1984
Box 1
Publication 201. "Characterization of an Oligopeptide Chemoattractant Receptor on Human Blood Monocytes Using a New Radioligand", 1984
Box 1
Publication 202. "Chemoattractant Receptors on Phagocytic Cells", 1984
Box 1
Publication 203. "Transductional Mechanisms of Chemoattractant Receptors on Leukocytes", 1984
Box 1
Publication 204. "Immunosuppressive Activity of the Retroviral Envelope Protein P15E and its Possible Relationship to Neoplasia", 1984
Box 1
Publication 205. "Simularity Between P15E of Murine and Feline Leukaemia Viruses and P21 of HTLV", 1984
Box 1
Publication 206. "Regulatory Mechanisms of a Chemoattractant Receptor on Leukocytes", 1984
Box 1
Publication 207. "Light Scattering by Polymorphonuclear Leukocytes Stimulated to Aggregate Under Various Pharmacologic Conditions", 1984
Box 1
Publication 208. "The NADPH Oxidase of Human Polymorphonuclear Leukocytes: Evidence for Regulation by Multiple Signals", 1984
Box 1
Publication 209. "Mechanisms of Monocyte and Macrophage Chemotaxis", 1984
Box 1
Publication 210. "Leukocyte Chemoattractant Receptors", 1984
Box 1
Publication 211. "Behcet's Disease", 1985
Box 1
Publication 212. "Mechanisms of Inflammation and Tissue Destruction in the Rheumatic Diseases", 1985
Box 1
Publication 213. "Structure and Function of Monocytes and Macrophages", 1985
Box 1
Publication 214. "Humoral Immunity", 1985
Box 1
Publication 215. "Potential Role for a Guanine Nucleotide Regulatory Protein in Chemoattractant Receptor and Mediated Polyphosphoinositide Metabolism, Ca++ Mobilization and Cellular Responses by Leukocytes", 1985
Box 1
Publication 216. "Activation of the Respiratory Burst Enzyme from Human Neutrophils in a Cell-Free System", 1985
Box 1
Publication 217. "Chemoattractant Receptor-Induced Hydrolysis of Phosphatidylinositol 4, 5-Bisphosphate in Human Polymorphonuclear Leukocyte Membranes", 1985
Box 1
Publication 218. "Regulatory Mechanisms of a Chemoattractant Receptor on Human Polymorphonuclear Leukocytes", 1985
Box 1
Publication 219. "Chemoattractant-Elicited Alterations of cAMP Levels in Human Polymorphonuclear Leukocytes Require a Ca2+-Dependent Mechanism Which Is Independent of Transmembrane Activation of Adenylate Cyclase", 1985
Box 1
Publication 220. "A Potential Second Messenger Role for Arachidonic Acid: Activation of Ca2+-Dependent Protein Kinase", 1985
Box 1
Publication 221. "Inhaled Asbestos Activates a Complement-Dependent Chemoattractant for Macrophages", 1985
Box 1
Publication 222. "Phorbol Myristate Acetate Mediates Redistribution of Protein Kinase C in Human Neutrophils: Potential Role in the Activation of the Respiratory Burst Enzyme", 1985
Box 1
Publication 223. "Successful Tumour Immunotherapy: Possible Role of Antibodies to Anti-Inflammatory Factors Produced by Neoplasms", 1985
Box 1
Publication 224. "Inhibition of Lymphocyte Proliferation by a Synthetic Peptide Homologous to Retroviral Envelope Proteins", 1985
Box 2
Publication 225. "Stimulus-Response Coupling of a Chemoattractant Receptor on Mononuclear Phagocytes", 1985
Box 2
Publication 226. "Redistribution of Protein Kinase C Activity in Human Monocytes: Correlation with Activation of the Respiratory Burst", 1985
Box 2
Publication 227. "Regulation of Mononuclear Leukocyte Function by Transmethylation Reactions", 1985
Box 2
Publication 228. "Chemoattractant Receptor-Induced Leukocyte Activation and Polyphosphoinositide Degredation is Mediated by a Guanine Nucleotide Regulatory Protein", 1985
Box 2
Publication 229. "The Role of the Neutrophil in the Inflammatory Response", 1985
Box 2
Publication 230. "Biochemical Regulation of a Chemoattractant Receptor on Mononuclear Phagocytes: A Potential Role for a Guanine Nucleotide Regulatory Unit, Phospholipase Activation and Protein Kinase C", 1985
Box 2
Publication 231. "Mechanisms of Inflammation and Leukocyte Chemotaxis in the Rheumatic Diseases", 1986
Box 2
Publication 232. "Receptor-Coupled Activation of Phosphoinositide-Specific Phospholipase C by an N Protein", 1986
Box 2
Publication 233. "Chemoattractant-Mediated Stimulation of the Respiratory Burst in Human Polymorphonuclear Leukocytes May Require Appearance of Protein Kinase Activity in the Cells' Particulate Fraction", 1986
Box 2
Publication 234. "Extensive Hydrolysis of N-Formyl-L-Methionyl-L-Leucyl-L-[3H] Phenylalanine by Human Polymorphonuclear Leukocytes", 1986
Box 2
Publication 235. "Suppression of the Respiratory Burst of Human Monocytes by a Synthetic Peptide Homologous to Envelope Proteins of Human and Animal Retroviruses", 1986
Box 2
Publication 236. "A Guanine Nucleotide Regulatory Protein Controls Polyphosphoinositide Metabolism, Ca2+ Mobilization, and Cellular Responses to Chemoattractants in Human Monocytes", 1986
Box 2
Publication 237. "Differential Stimulation of the Respiratory Burst and Lysosomal Enzyme Secretion in Human Polymorphonuclear Leukocytes by Synthetic Diacylglycerols", 1986
Box 2
Publication 238. "Effects of Tumor Growth on Host Defenses", 1986
Box 2
Publication 239. "A Pertussis/Choleratoxin-Sensitive N Protein May Mediate Chemoattractant Receptor Signal Transduction", 1986
Box 2
Publication 240. "Component Deficiencies 5. The Fifth Component", 1986
Box 2
Publication 242. "Role of a Guanine Nucleotide Regulatory Protein in Polyphosphoinositide Degradation and Activation of Phagocytic Leukoctyes by Chemoattractants", 1986
Box 2
Publication 243. "Model for Leukocyte Regulation by Chemoattractant Receptors: Roles of a Guanine Nucleotide Regulatory Protein and Polyphosphoinositide Metabolism", 1986
Box 2
Publication 244. "Coexistence of a Chemotactic Factor and a Retroviral P15E-Related Chemotaxis Inhibitor in Human Tumor Cell Culture Supernatants", 1986
Box 2
Publication 245. "Inhibition of Human Natural Killer Cell Activity by a Synthetic Peptide Homologous to a Conserved Region in the Retroviral Protein, P15E", 1987
Box 2
Publication 246. "Suppressive Effect on Polyclonal B-Cell Activation of a Synthetic Peptide Homologous to a Transmembrane Component of Oncogenic Retroviruses", 1987
Box 2
Publication 247. "Human Gi Protein [alpha]-Subunit: Deduction of Amino Acid Structure from a Cloned cDNA", 1987
Box 2
Publication 248. "Regulation of Leukocyte Responses to Chemoattractants: Role of Receptors, Guanine Nucleotide Regulatory (N) Proteins and Phospholipase C", 1987
Box 2
Publication 249. "Identification of a Novel Inositol Bisphosphate Isomer Formed in Chemoattractant Stimulated Human Polymorphonuclear Leukocytes", 1987
Box 2
Publication 250. "Nucleotide Regulatory Protein-Mediated Activation of Phospholipase C in Human Polymorphonuclear Leukoctyes Is Disrupted by Phorbol Esters", 1987
Box 2
Publication 251. "Leukocyte Activation by Chemoattractant Receptors: Roles of a Guanine Nucleotide Regulatory Protein and Polyphosphoinositide Metabolism", 1987
Box 2
Publication 252. "Role of a Guanine Nucleotide Regulatory Protein in the Activation of Phospholipase C By Different Chemoattractants", 1987
Box 2
Publication 253. "Chemoattractant-Induced Activation of c-fos Gene Expression in Human Monocytes", 1987
Box 2
Publication 254. "Regulation of Inositol Metabolism in Chemoattractant-Stimulated Human Polymorphonuclear Leukocytes", 1987
Box 2
Publication 255. "Molecular Cloning of a New Human G Protein", 1987
Box 2
Publication 256. "Isolation of GTP-Binding Proteins from Myeloid HL-60 Cells", 1987
Box 2
Publication 257. "Recombinant Hydrophilic Region of Murine Retroviral Protein P15E Inhibits Stimulated T-Lymphocyte Proliferation", 1987
Box 2
Publication 258. Review of the National Arthritis Advisory Board Symposium: "Molecular Biology: Its Potential for Advancing Rheumatology Research", 1987
Box 2
Publication 259. "Altered Cell-Averaged Microviscosity of Murine Peritoneal Macrophages Undergoing Activation in Vivo or in Vitro", 1987
Box 2
Publication 260. "Regulation of Inositol Phospholipid and Inositol Phosphate Metabolism in Chemoattractant-Activated Human Polymorphonuclear Leukocytes", 1987
Box 2
Publication 261. "Chemotactic Factor and P15E-Related Chemotaxis Inhibitor in Human Melanoma Cell Lines with Different Macrophage Content and Tumorigenicity in Nude Mice", 1987
Box 2
Publication 262. "A Synthetic Peptide Homologous to the Envelope Proteins of Retroviruses Inhibits Monocyte-Mediated Killing by Inactivating Interleukin", 1987
Box 2
Publication 263. "Lymphoma Models for B Cell Activation and Tolerance", 1987
Box 2
Publication 264. "Guanine Nucleotide Regulatory Proteins in Receptor-Mediated Polyphosphoinositide Hydrolysis in Human Leukoctyes", 1987
Box 2
Publication 265. "A Conserved Region at the C-Terminus of Human Immunodeficiency Virus gp120 Envelope Protein Contains an Immunodominant Epitope", 1987
Box 2
Publication 266. "Molecular Cloning of a Novel Human GTP-Binding Protein and its Potential Role in Chemoattractant Stimulus-Response Coupling", 1987
Box 2
Publication 267. "Role of a Guanine Nucleotide Regulatory Protein in the Polyphosphoinositide Pathway of Leukocyte Activation by Chemoattractant Receptors", 1987
Box 2
Publication 268. "Stimulus-Response Coupling Mechanisms", 1988
Box 2
Publication 269. "Calcium Influx Stimulates a Second Pathway for Sustained Diacylglycerol Production in Leukocytes Activated by Chemoattractants", 1988
Box 2
Publication 270. "The Formylpeptide Chemoattractant Receptor Copurifies with a GTP-Binding Protein Containing a Distinct 40-kDa Pertussis Toxin Substrate", 1988
Box 2
Publication 271. "Binding of [alpha]2-Macroglobulin-Thrombin Complexes and Methylamine-Treated [alpha]2-Macroglobulin to Human Blood Monocytes", 1988
Box 2
Publication 272. "Mechanisms of Inflammation and Tissue Destruction in the Rheumatic Diseases", 1988
Box 2
Publication 273. "Behcet's Disease", 1988
Box 2
Publication 274. "Immunopathology", 1988
Box 2
Publication 275. "Signal Transduction in Cells Following Binding of Chemoattractants to Membrane Receptors", 1988
Box 2
Publication 276. "Retroviral Protein P15E and Tumorgenesis: Expression Is Neither Required Nor Sufficient for Tumor Development", 1988
Box 2
Publication 277. "Human IFN-[gamma] Production is Inhibited by a Synthetic Peptide Homologous to Retroviral Envelope Protein", 1988
Box 2
Publication 278. "Chemoattractant Receptors and Signal Transduction Processes", 1988
Box 2
Publication 279. "Leukocyte Chemoattraction by 1,2-Diacylglycerol", 1988
Box 2
Publication 280. "Modulation of Inositol Phospholipid Metabolism by Polyamines", 1988
Box 2
Publication 281. "Human Retrovirus-Related Synthetic Peptides Inhibit T Lymphocyte Proliferation", 1988
Box 2
Publication 282. "Leukocyte Chemoattractant Receptors", 1988
Box 2
Publication 283. "Chemoattractant-Induced Membrane Phenomena of Phagocytes", 1988
Box 2
Publication 284. "Biochemical Changes in Leukocytes in Response to Chemoattractants", 1988
Box 2
Publication 285. "Behcet's Disease: Provocative Clues", 1988
Box 2
Publication 286. "Mapping of Immunogenic and Immunodominant Epitopes of Human Immunodeficiency Virus with ENV-Encoded Synthetic Peptides", 1988
Box 2
Publication 287. "Inflammation and Chemotaxis", 1989
Box 2
Publication 288. "Analysis of Calcium Homeostasis in Activated Human Polymorphonuclear Leukocytes", 1989
Box 2
Publication 289. "Structure and Function of Monocytes and Macrophages", 1989
Box 2
Publication 290. "Characterization of G25K, a GTP-Binding Protein Containing a Novel Putative Nucleotide Binding Domain", 1989
Box 2
Publication 291. "Substance P Primes Human Neutrophil Activation: A Mechanism for Neurological Regulation of Inflammation", 1989
Box 2
Publication 292. "Multiple Chromatographic Forms of the Formylpeptide Chemoattractant Receptor and Their Relationship to GTP-Binding Proteins", 1989
Box 2
Publication 293. "Role of Chemotactic and Inflammatory Cytokines", 1989
Box 2
Publication 294. "Chemotaxis and Chemotactic Factors", 1989
Box 2
Publication 295. "Signal Transduction and Intracellular Messengers", 1989
Box 2
Publication 296. "Stimulation of Phosphorylcholine Turnover and Diacylglycerol Production in Human Polymorphonuclear Leukoctyes", 1989
Box 2
Publication 297. "Mastoparan, a Wasp Venom Peptide, Identifies Two Discrete Mechanisms for Elevating Cytosolic Calcium and Inositol Trisphosphates in Human Polymorphonuclear Leukoctyes", 1989
Box 2
Publication 298. "Rac, a Novel Ras-Related Family of Proteins That Are Botulinum Toxin Substrates", 1989
Box 2
Publication 299. "Identification of the Ral and Rac1 Gene Products, Low Molecular Mass GTP-Binding Proteins from Human Platelets", 1989
Box 2
Publication 300. "Production of a Retroviral P15E-Related Chemotaxis Inhibitor by Il-1-Treated Endothelial Cells", 1989
Box 2
Publication 301. "Molecular Cloning of the cDNA for Ligatin", 1989
Box 2
Publication 302. "Effects of CKS-17, a Synthetic Retroviral Envelope Peptide, on Cell-Mediated Immunity in Vivo: Immunosuppression, Immunogenicity, and Relation to Immunosuppressive Tumor Products", 1989
Box 2
Publication 303. "G Proteins and Neutrophil Function", 1990
Box 2
Publication 304. "Isoprenylation of the Low Molecular Mass GTP-Binding Proteins Rac 1 and Rac 2: Possible Role in Membrane Localization", 1990
Box 2
Publication 305. "Immunopathology", 1991
Box 2
Publication 306. "Molecular Basis of Leukocyte Chemotactic Responses", 1991
Box 2
Publication 307. "Molecular Mechanisms of Leukocyte Activation by Chemoattractants", 1991
Box 2
Publication 308. "A Synthetic Peptide Homologous to Retroviral Transmembrane Envelope Proteins Depresses Protein Kinase C Mediated Lymphocyte Proliferation and Directly Inactivated Protein Kinase C: A Potential Mechanism for Immunosuppression", 1991
Box 2
Publication 309. "Receptor Class Desensitization of Leukocyte Chemoattractant Receptors", 1991
Box 2
Publication 310. "Differential Regulation of cAMP by Endogenous Versus Transfected Formylpeptide Chemoattractant Receptors: Implications for Gi-Coupled Receptor Signaling", 1992
Box 2
Publication 311. "Functional High Efficiency Expression of Cloned Leukocyte Chemoattractant Receptor cDNAs", 1992
Box 2
Publication 312. "Both Stimulatory and Inhibitory GDP/GTP Exchange Proteins, smg GDS and rho GDI, are Active on Multiple Small GTP-Binding Proteins", 1992
Box 2
Publication 313. "Rac1, a Low-Molecular-Mass GTP-Binding Protein with High Intrinsic GTPase Activity and Distinct Biochemical Properties", 1992
Box 2
Publication 314. "Chemoattractant Stimulus-Response Coupling", 1992
Box 2
Publication 315. "Chemoattractant Stimulus-Response Coupling", 1992
Box 2
Publication 316. "Differences in Phosphorylation of Formylpeptide and C5a Chemoattractant Receptors Correlate with Differences in Desensitization", 1993
Box 2
Publication 317. "Identification of Additional Members of Human G-Protein-Coupled Receptor Kinase Multigene Family", 1993
Box 2
Publication 318. "Role of Phosphate-Magnesium-Binding Regions in the High GTPase Activity of Rac1 Protein", 1993
Box 2
Publication 319. "Science, Technology, and Societal Goals", 1993
Box 2
Publication 320. "Receptor-Cross-Desensitization of Peptide Chemoattractant Receptors", 1994
Box 2
Publication 321. "Regulation of Stably Transfected Platelet Activating Factor Receptor in RBL-2H3 Cells", 1994
Box 2
Publication 322. "Cultural and Organizational Implications of Academic Managed-Care Networks", 1994
Box 2
Publication 323. "Human Calcium-Calmodulin Dependent Protein Kinase I", 1995
Box 2
Publication 324. "Inherited Human Complement C5 Deficiency", 1995
Box 2
Publication 325. "Overview: The Evolution of the Academic Health Center in Health Care Reform", 1995
Box 2
Publication 326. "Regulation of Human Interleukin-8 Receptor A: Identification of a Phosphorylation Site Involved in Modulating Receptor Functions", 1995
Box 2
Publication 327. "Cross-Desensitization of Chemoattractant Receptors Occurs at Multiple Levels", 1995
Box 2
Publication 328. "The Role of Subspecialty Programs in Departments of Internal Medicine in Markets with Major Penetration of Managed Care Networks", 1995
Box 2
Publication 329. "Model for a 21st Century Academic Health System", 1995
Box 2
Publication 330. "Thrombin Primes Responsiveness of Selective Chemoattractant Receptors at a Site Distal to G Protein Activation", 1996
Box 2
Publication 331. "Cross-Desensitization Among Receptors for Platelet Activating Factor and Peptide Chemoattractants", 1996
Box 2
Publication 332. "Development of Academic Health Systems" in "The AHC Responds to Health Care Reform" Conference Overview, 1996
Box 2
Publication 333. "Chemoattractant Receptor-Induced Phosphorylation of L-Selectin", 1997
Box 2
Publication 334. "Mechanisms of Inflammation and Leukocyte Activation", 1997
Box 2
Publication 335. "Role of Phospholipase C[beta]3 Phosphorylation in the Desensitization of Cellular Responses to Platelet-Activating Factor", 1997
Box 2
Publication 336. "Regulation of Human Chemokine Receptors CXCR4: Role of Phosphorylation in Desensitization and Internalization", 1997
Box 2
Publication 337. "Beyond Managed Care: The Role of the Academic Health Center", 1997
Box 2
Publication 338. "Chemoattractant Stimulus-Response Coupling", 1999
Box 2
Publication 339. "Multiple Signaling Pathways of Human Interleukin-8 Receptor A: Independent Regulation by Phosphorylation", 1998
Box 2
Publication 340. "Differential Regulation of Formyl Peptide and Platelet-Activating Factor Receptors", 1998
Box 2
Publication 341. "Restructuring the Research Enterprise for the Future", 1998
Box 2
Publication 342. "Differential Cross-Regulation of the Human Chemokine Receptors CXCR1 and CXCR2: Evidence for Time-Dependent Signal Generation", 1998
Box 2
Publication 343. "Opiates Transdeactivate Chemokine Receptors: [delta] and [mu] Opiate Receptor-Mediated Heterologous Desensitization", 1998
Box 2
Publication 344. "Integrating Health Care Delivery Systems: Developing an Integrated Health Care System", 1998
Box 2
Publication 345. "Chemoattractant Receptor Cross-Desensitization", 1999
Box 2
Publication 346. "Chemoattractant Receptors Activate Distinct Pathways for Chemotaxis and Secretion", 1999
Box 2
Publication 347. "Academic Medicine Can Transform Health Care Through Clinical Research", 1999
Box 2
Publication 348. "Identification of a Region at the N-Terminus of Phospholipase C-[beta]3 That Interacts with G Protein [beta][gamma] Subunits", 2000
Box 2
Publication 349. "Integrated Health Delivery Systems: Systems of Accountability", 2000
Box 2
Publication Unnumbered. "Ralph Snyderman: Of Science and Healing", 1992
Box 2
Publication Unnumbered. AAMC Reporter: President's Advisory Committee Testimony, December 1997 / January 1998
Box 2

Manuscript Materials, 1968-2002

Subseries Scope and Contents: Manuscript materials include correspondence to and from editors, co-authors, and reviewers; page proofs; manuscript drafts; prints of corresponding visuals such as tables, charts, or figures; reviewers' comments; and photocopies and reprints of the published articles. Materials span 1968 to 2002.

"Interactions of the Complement System with Endotoxic Lipopolysaccharide", 1968-1983
Box 3
"Further Characterization of a Factor from Endotoxin-Treated Serum which Releases Histamine and Heparin from Mast Cells", 1972
Box 3
"Humoral Mediators of Chemotaxis of Mononuclear Leukocytes", 1972
Box 3
"Inflammation and Viral Infection: Chemotactic Activity Resulting from the Interaction of Antiviral Antibody and Complement with Cells Infected with Herpes Simplex Virus", 1972
Box 3
"Macrophage Proteinase and Inflammation: The Production of Chemotactic Activity from the Fifth Component of Complement by Macrophage Proteinase", 1972
Box 3
"Cytogenetic Engineering In Vivo: Restoration of Biologic Complement Activity to C5 Deficient Mice by Intravenous Inoculation of Hybrid Cells", 1973
Box 3
"Immunological Mechanisms of Periodontal Tissue Destruction", 1973
Box 3
"Mediators of Delayed Hypersensitivity", 1973
Box 3
"The Role of the Immune Response in the Development of Periodontal Disease", 1973
Box 3
Inactive Manuscripts, 1973-1976
Box 3
"Induction of Cellular Immunity to Coccidiodes Immitis Following Sensitization with Dinitrochlorobenzene", 1973-1981
Box 3
"Production of Chemotactic Factor and Lymphotoxin by Human Leukocytes Stimulated with Herpes Simplex Virus", 1974
Box 3
"Defective Monocyte Function in Patients with Genitourinary Carcinoma", 1974-1975
Box 3
"The Role of Lymphokines in Delayed Hypersensitivity Reactions", 1974-1976
Box 3
"Chemotaxis of Macrophages", 1974-1980
Box 3
"Depressed Monocyte Chemotaxis During Acute Influenza Infection", 1975
Box 3
"Interaction of Complex Polysaccharides with the Complement System: Effect of Calcium Depletion on Terminal Component Consumption", 1975
Box 3
"Quantification of Mouse Macrophage Chemotaxis in Vitro: Role of C5 for the Production of Chemotactic Activity", 1975
Box 3
"Chemotaxis of Mononuclear Cells", 1975
Box 3
"Effect of Virus Infection on the Inflammatory Response", 1975-1976
Box 3
"Effects of Neoplasms on Inflammation: Depression of Macrophage Accumulation After Tumor Implantation", 1975-1976
Box 3
"Identification of [Beta]-Adrenergic Receptors in Human Lymphocytes by (-) [3H] Alprenolol Binding", 1975-1976
Box 3
"Prostaglandins and Inflammation: Enhancement of Monocyte Chemotactic Responsiveness by Prostaglandin E2", 1975-1976
Box 3
"Mechanisms of Inflammation in Periodontal Disease", 1975-1977
Box 3
"The Chemotactic Attraction of Human Fibroblasts to a Lymphocyte-Derived Factor", 1976
Box 3
"Defective Macrophage Migration Produced by Neoplasms: Identification of an Inhibitor of Macrophage Chemotaxis", 1976
Box 3
"Depression of Macrophage Function by a Factor Produced by Neoplasms: A Mechanism for Abrogation of Immune Surveillance", 1976
Box 3
"Human Lymphocyte Motility: Normal Characteristics and Anomalous Behavior of Chronic Lymphocytic Leukemia Cells", 1976
Box 3
"The Role of Cell-Mediated Immunity in Atopic Diseases", 1976
Box 3
"Influenza-Induced Depression of Monocyte Chemotaxis: Reversal by Levamisole", 1976-1977
Box 3
"Reversal of Influenza Induced Depression of Monocyte Chemotaxis by Levamisole", 1976-1977
Box 3
"Specific Receptor Sites for Chemotactic Peptides on Human Polymorphonuclear Leukocytes", 1976-1977
Box 3
"Quantification of Lymphokine Production in Human Disease", 1976-1977
Box 3
"Immunosuppressive Activity of the Retroviral Envelope Protein P15E and its Possible Relationship to Neoplasia", 1976-1986
Box 3
"Disorders of Leukocyte Chemotaxis", 1977
Box 3
"Eular Multicenter Trial of Levamisole in Rheumatoid Arthritis: Interim Analysis, June 1977", 1977
Box 3
"Generalized Microsporum Audouinii Infection and Depressed Cellular Immunity Associated with a Missing Plasma Factor Required for Lymphocyte Blastogenesis", 1977
Box 3
"Macrophage Migratory Dysfunction in Cancer", 1977
Box 3
"The Inflammatory Response and Resistance to Endotoxin in Mice", 1977-1978
Box 3
"Methodology for Monocyte and Macrophage Chemotaxis", 1977-1978
Box 3
"Pathophysiologic Aspects of a Leukocyte Chemotaxis: Identification of a Specific Chemotactic Factor Binding Site on Human Granulocytes and Defects of Macrophage Function Associated with Neoplasia", 1977-1978
Box 4
"The Role of Macrophages in the Rheumatic Diseases", 1977-1978
Box 4
"Generation of a Fibroblast Chemotactic Factor in Serum by Activation of Complement", 1977-1979
Box 4
"Mechanisms of Nonspecific Host Resistance" for "Immunodermatology", 1977-1981
Box 4
"Chemotaxis and the Complement System: Methodology to Quantify a Biological Activity of Complement in Humans", 1978
Box 4
"Clinical Usefulness of Hemolytic Complement Determination", 1978
Box 4
"Familial Deficiency of the Seventh Component of Complement Associated with Recurrent Bacteremic Infections Due to Neisseria", 1978
Box 4
"Inflammation and the Complement System", 1978
Box 4
"Letter to the Editor," "New England Journal of Medicine", 1978
Box 4
"Levamisole and Human Monocyte Chemotaxis: Reversal of an Influenzal-Induced Chemotactic Defect", 1978
Box 4
"Requirement of S-adenosyl-L-Methionine-Mediated Methylation for Human Monocyte Chemotaxis", 1978
Box 4
"Resistance of Neoplasms to Immunological Destruction: Role of a Macrophage Chemotaxis Inhibitor", 1978
Box 4
"Do Macrophages Destroy Nascent Tumors", 1978-1979
Box 4
"Hereditary C2 Deficiency Associated with Cutaneous Lupus Erythematosus", 1978-1979
Box 4
"Laboratory Testing in the Rheumatic Diseases", 1978-1979
Box 4
"Neisseria Meningitidis and Neisseria Gonorrhoeae Bacteremia Associated with C6, C7 or C8 Deficiency", 1978-1979
Box 4
"Neisseria Meningitidis Bacteremia in Association with Deficiency of the Sixth Component of Complement", 1978-1979
Box 4
"Phospholipid Methylation in Macrophages is Inhibited by Chemotactic Factors", 1978-1979
Box 4
"Rheumatoid Nodulosis. Sporadic and Familial Diseases", 1978-1979
Box 4
"Stimulation of Neutrophil Oxidative Metabolism by Chemotactic Peptides: Influence of Calcium Ion Concentration and Cytochalasin B and Comparison with Stimulation by Phorbol Myristate Acetate", 1978-1979
Box 4
"Role of Transmethylation Reactions in Cellular Motility and Phagocytosis", 1978-1982
Box 4
"Chemotaxis of Human and Murine Mononuclear Phagocytes", 1979
Box 4
"Chronic Mucocutaneous Candidiasis: Immunologic Studies of Three Generations of a Single Family", 1979
Box 4
"Laboratory Testing in the Rheumatic Diseases: Avoiding the Pitfalls", 1979
Box 4
"Laboratory Testing in the Rheumatic Diseases: Current Perspectives", 1979
Box 4
"The Role of Macrophages in Tumor Immunology" Symposium Manuscripts, 1979
Box 4
"Deficiency of the Fifth Component of Complement in Human Subjects", 1979-1980
Box 39
"Deficiency of the Fifth Component of Complement in Human Subjects" [oversized], undated
Box 4
"Demonstration of a Chemotactic Factor Receptor on Macrophages", 1979-1980
Box 4
"Depression of Murine Macrophage Accumulation by Low-Molecular-Weight Factors Derived from Spontaneous Mammary Carcinomas", 1979-1980
Box 4
"Genetic Control of Leukocyte Responses to Endotoxic Lipopolysaccharides in Mice", 1979-1980
Box 4
"Genetic Control of Peripheral Leukocyte Response to Endotoxin in Mice", 1979-1980
Box 4
"In Vitro Methods for the Study of Macrophage Chemotaxis", 1979-1980
Box 4
"Influence of Cytoskeletal Assembly on Phosphatidylcholine Synthesis in Intact Phagocytic Cells", 1979-1980
Box 4
"Lipid Requirements for Leukocyte Chemotaxis and Phagocytosis: Effects of Inhibitors of Phospholipid and Cholesterol Synthesis", 1979-1980
Box 4
"Macrophage Accumulation in Mice is Inhibited by Low Molecular Weight Products from Murine Leukemia Viruses", 1979-1980
Box 4
"N-Formylmethionyl Peptide Receptors on Equine Leukocytes Initiate Secretion but not Chemotaxis", 1979-1980
Box 4
"Quantification of Macrophage Accumulation in Vivo", 1979-1981
Box 5
"Requirement of Transmethylation Reactions for Immune Effector Function", 1979-1981
Box 39
"Requirement of Transmethylation Reactions for Immune Effector Function" [oversized], 1981
Box 5
"Effect of Neoplasms on Mononuclear Phagocytes", 1979-1982
Box 5
"Neoplasia and Mononuclear Phagocyte Function", 1979-1983
Box 5
Inactive Manuscripts, 1979-1984
Box 5
"Chemotactic Factor Receptors on Leukocytes", 1980
Box 5
"Chemotactically Responsive and Nonresponsive Forms of a Continuous Human Monocyte Cell Line", 1980
Box 5
"Development of Specific Receptors for N-Formylated Chemotactic Peptides in a Human Monocyte Cell Line Stimulated with Lymphokines", 1980
Box 5
"Letter to the Editor," "Journal of Immunology", 1980
Box 5
"Monocyte Responsiveness to Chemotactic Stimuli is a Property of a Subpopulation of Cells that can Respond to Multiple Chemoattractants", 1980
Box 5
"Specific Receptors and Transmethylation Reactions in Macrophages: A Model for Macrophage Chemotaxis", 1980
Box 5
"Quantification of Monocyte Function in Patients with Cancer: Evidence for a Tumor Mediated Dysfunction", 1980-1981
Box 5
"Quantitation of the Inflammatory Accumulation of Mononuclear Phagocytes in Vivo", 1980-1981
Box 5
"Receptors and Transductional Events in Leukocyte Chemotaxis", 1980-1981
Box 5
"The Role of Transmethylation Reactions in Regulating the Binding of BCG-Activated Murine Macrophages to Neoplastic Target Cells", 1980-1981
Box 5
"Chemoattractant-Receptor Interactions in Leukocytes", 1980-1982
Box 5
"Disorders of Human Leukocyte Chemotaxis", 1980-1982
Box 5
"IgA Paraprotein Inhibits Chemotactic Factor Binding to Human Polymorphonuclear Leukocytes" (folder 1 of 2), 1980-1982
Box 5
"IgA Paraprotein Inhibits Chemotactic Factor Binding to Human Polymorphonuclear Leukocytes" (folder 2 of 2), 1980-1982
Box 5
"Mechanisms of Inflammation and Tissue Destruction in the Rheumatic Diseases", 1980-1982
Box 5
"Specific Receptors and Transmethylation Reactions are Required for Leukocyte Chemotaxis", 1980-1982
Box 5
"Molecular and Cellular Mechanisms of Leukocyte Chemotaxis", 1980-1985
Box 5
"Alterations of New Methylated Phospholipid Synthesis in the Plasma Membranes of Macrophages Exposed to Chemoattractants", 1981
Box 5
"Binding of Synthetic Chemotactic Peptides as a Model of Ligand-Receptor Interaction", 1981
Box 5
"Differential Anti-Inflammatory Effects of LPS in Susceptible and Resistant Mouse Strains", 1981
Box 5
"Immunology" for "Science Year" 1982, 1981
Box 6
"Inhibitors of Monocyte Responses to Chemotaxins Are Present in Human Cancerous Effusions and React with Monoclonal Antibodies to the P15(E) Structural Protein of Retroviruses" (folder 1 of 2), 1981
Box 6
"Inhibitors of Monocyte Responses to Chemotaxins Are Present in Human Cancerous Effusions and React with Monoclonal Antibodies to the P15(E) Structural Protein of Retroviruses" (folder 2 of 2), 1981
Box 6
"Transmethylation Reactions are Required for Initial Morphologic and Biochemical Responses of Human Monocytes to Chemoattractants", 1981
Box 6
"Cyclic Nucleotides Regulate the Morphologic Alterations Required for Chemotaxis in Monocytes", 1981-1982
Box 6
"Endotoxin (LPS) Stimulates in Vitro Migration of Macrophages from LPS Resistant Mice but not from LPS Sensitive Mice", 1981-1982
Box 6
"The Oligopeptide Chemotactic Factor Receptor on Human Polymorphonuclear Leukocyte Membranes Exists in Two Affinity States", 1981-1982
Box 6
"Transmethylation Reactions Regulate Affinity and Functional Activity of Chemotactic Factor Receptors on Macrophages", 1981-1982
Box 6
"Polymorphonuclear Leukocyte Function in Psoriasis: Chemotaxis, Chemokinesis, Beta-adrenergic Receptors and Proteolytic Enzymes of Polymorphonuclear Leukocytes in the Peripheral Blood from Psoriatic Patients", 1981-1983
Box 6
"Immunology" for "Science Year" 1983, 1982
Box 6
"Chemoattractant Receptor Affinity Reflects its Ability to Transduce Different Biological Responses", 1982-1983
Box 6
"Guanine Nucleotides Modulate the Binding Affinity of the Oligopeptide Chemoattractant Receptor on Human Polymorphonuclear Leukocytes", 1982-1983
Box 39
"Guanine Nucleotides Modulate the Binding Affinity of the Oligopeptide Chemoattractant Receptor on Human Polymorphonuclear Leukocytes" [oversized], undated
Box 6
"Hormonal Activation of Adenylate Cyclase in Macrophage Membranes is Regulated by Guanine Nucleotides", 1982-1983
Box 6
"Leukocyte Chemotaxis" FASEB Minisymposium Report, 1982-1983
Box 6
"Pharmacological Manipulation of the Chemotactic Factor Receptor on Leukocytes", 1982-1983
Box 6
"Chemoattractant Receptor Functions in Human Polymorphonuclear Leukocytes are Divergently Altered by Membrane Fluidizers", 1982-1984
Box 6
"Mechanisms of Monocyte and Macrophage Chemotaxis", 1982-1984
Box 6
"Humoral Immunity in Rheumatoid Arthritis" (folder 1 of 2), 1982-1985
Box 6
"Humoral Immunity in Rheumatoid Arthritis" (folder 2 of 2), 1982-1985
Box 6
"Leukocyte Chemoattractant Receptors" (folder 1 of 2), 1982-1985
Box 6
"Leukocyte Chemoattractant Receptors" (folder 2 of 2), 1982-1985
Box 7
"Structure and Function of Monocytes and Macrophages", 1982-1986
Box 7
"Characterization of the Oligopeptide Chemoattractant Receptor on Leukocytes: Binding Affinity Reflects Signal Transduction", 1983
Box 7
"Chemoattractant Receptors are Decreased on Polymorphonuclear Leukocytes from Patients with Chediak-Higashi Syndrome", 1983
Box 7
"Induction of Selective Biological Responses to Chemoattractants in a Human Monocyte-Like Cell Line", 1983
Box 39
"Induction of Selective Biological Responses to Chemoattractants in a Human Monocyte-Like Cell Line" [oversized], undated
Box 7
"Murine Malignant Cells Synthesize a 19,000 Dalton Protein Which is Physicochemically and Antigenically Related to the Immunosuppressive Retroviral Protein, P15E", 1983
Box 7
"Pharmacologic Manipulation of Leukocyte Chemotaxis: Present Knowledge and Future Trends", 1983
Box 7
"Chemoattractant Receptors on Phagocytic Cells", 1983-1984
Box 39
"Chemoattractant Receptors on Phagocytic Cells" [oversized], circa 1984
Box 7
"Human Malignant and Mitogen-Transformed Cells Contain Retroviral P15E-Related Antigen", 1983-1984
Box 7
"Light Scattering by Polymorphonuclear Leukocytes Stimulated to Aggregate Under Various Pharmacologic Conditions", 1983-1984
Box 7
"The NADPH Oxidase of Human Polymorphonuclear Leukocytes: Evidence for Regulation by Multiple Signals", 1983-1984
Box 7
"Oligopeptide Chemoattractant Receptors on Human Polymorphonuclear Leukocytes Convert to a Guanine Nucleotide Insensitive High Affinity State Following Agonist Exposure (folder 1 of 3), 1983-1984
Box 7
"Oligopeptide Chemoattractant Receptors on Human Polymorphonuclear Leukocytes Convert to a Guanine Nucleotide Insensitive High Affinity State Following Agonist Exposure (folder 2 of 3), 1983-1984
Box 7
"Oligopeptide Chemoattractant Receptors on Human Polymorphonuclear Leukocytes Convert to a Guanine Nucleotide Insensitive High Affinity State Following Agonist Exposure (folder 3 of 3), 1983-1984
Box 39
"Oligopeptide Chemoattractant Receptors on Human Polymorphonuclear Leukocytes Convert to a Guanine Nucleotide Insensitive High Affinity State Following Agonist Exposure" [oversized], circa 1983-1984
Box 7
"Oxygen-Dependent Microbicidal Activity of Leukocytes", 1983-1984
Box 7
"Rapid Changes in Light Scattering from Human Polymorphonuclear Leukocytes Exposed to Chemoattractants (folder 1 of 2), 1983-1984
Box 7
"Rapid Changes in Light Scattering from Human Polymorphonuclear Leukocytes Exposed to Chemoattractants (folder 2 of 2), 1983-1984
Box 7
"Regulatory Mechanisms of a Chemoattractant Receptor on Leukocytes", 1983-1984
Box 7
"Transductional Mechanisms of Chemoattractant Receptors on Leukocytes", 1983-1984
Box 7
"Cecil Textbook of Medicine," 17th edition Manuscripts, 1983-1985
Box 39
"Cecil Textbook of Medicine," 17th edition Manuscripts [oversized], undated
Box 8
"Inhaled Asbestos Activates a Complement-Dependent Chemoattractant for Macrophages", 1983-1985
Box 8
"Regulatory Mechanisms of a Chemoattractant Receptor on Human Polymorphonuclear Leukocytes", 1983-1985
Box 8
"Characterization of an Oligopeptide Chemoattractant Receptor on Human Blood Monocytes Using a New Radioligand", 1984
Box 8
"Simularity between p15E of Murine and Feline Leukaemia Viruses and p21 of HTLV", 1984
Box 8
"Biochemical Regulation of a Chemoattractant Receptor on Mononuclear Phagocytes: A Potential Role for a Guanine Nucleotide Regulatory Unit, Phospholipase Activation and Protein Kinase C", 1984-1985
Box 8
"Chemoattractant-Elicited Alterations of cAMP Levels in Human Polymorphonuclear Leukocytes Require a Ca2+-dependent Mechanism Which is Independent of Transmembrane Activation of Adenylate Cyclase", 1984-1985
Box 8
"Phorbol Myristate Acetate Mediates Redistributions of Protein Kinase C in Human Neutrophils: Potential Role in the Activation of the Respiratory Burst Enzyme" (folder 1 of 2), 1984-1985
Box 8
"Phorbol Myristate Acetate Mediates Redistributions of Protein Kinase C in Human Neutrophils: Potential Role in the Activation of the Respiratory Burst Enzyme" (folder 2 of 2), 1984-1985
Box 8
"Potential Role for a Guanine Nucleotide Regulatory Protein in Chemoattractant Receptor Mediated Polyphosphoinositide Metabolism, Ca++ Mobilization and Cellular Responses by Leukocytes", 1984-1985
Box 8
"Redistribution of Protein Kinase C Activity in Human Monocytes: Correlation with Activation of the Respiratory Burst" (folder 1 of 2), 1984-1985
Box 8
"Redistribution of Protein Kinase C Activity in Human Monocytes: Correlation with Activation of the Respiratory Burst" (folder 2 of 2), 1984-1985
Box 8
"Regulation of Mononuclear Leukocyte Function by Transmethylation Reactions", 1984-1985
Box 8
"Stimulus-Response Coupling of a Chemoattractant Receptor on Mononuclear Phagocytes", 1984-1985
Box 8
"Successful Tumor Immunotherapy: Possible Role of Antibodies to Anti-Inflammatory Factors Produced by Neoplasms", 1984-1985
Box 8
"Chemoattractant-Mediated Stimulation of the Respiratory Burst in Human Polymorphonuclear Leukocytes May Require Appearance of Protein Kinase Activity in the Cells' Particulate Fraction", 1984-1986
Box 8
"Extensive Hydrolysis of N-Formyl-L-Methionyl-L-Leucyl-L-[3H] Phenylalanine by Human Polymorphonuclear Leukocytes", 1984-1986
Box 8
"Inflammation: Basic Principles and Clinical Correlates" (folder 1 of 4), 1984-1987
Box 8
"Inflammation: Basic Principles and Clinical Correlates" (folder 2 of 4), 1984-1987
Box 8
"Inflammation: Basic Principles and Clinical Correlates" (folder 3 of 4), 1984-1987
Box 9
"Inflammation: Basic Principles and Clinical Correlates" (folder 4 of 4), 1984-1987
Box 9
"Inflammation and Chemotaxis" (Chapter 14 in "Endocrinology," Second Edition) (folder 1 of 2), 1984-1988
Box 9
"Inflammation and Chemotaxis" (Chapter 14 in "Endocrinology," Second Edition) (folder 2 of 2), 1984-1988
Box 9
"cAMP-Mediated Inhibition of Receptor-Stimulated Polyphosphoinositide Hydrolysis in Human Polymorphonuclear Leukocytes: A Potential Autoregulatory Mechanism for Chemoattractant Receptor Signal Transduction", 1985
Box 9
"Chemoattractant Receptor-Induced Hydrolysis of Phosphatidylinositol 4, 5-Bisphosphate in Human Polymorphonuclear Leukocyte Membranes", 1985
Box 9
"Chemoattractant Receptor-Induced Leukocyte Activation and Polyphosphoinositide Degredation is Mediated by a Guanine Nucleotide Regulatory Protein", 1985
Box 9
"Inhibition of Lymphocyte Proliferation by a Synthetic Peptide Homologous to Retroviral Envelope Proteins", 1985
Box 9
"Differential Stimulation of the Respiratory Burst and Lysosomal Enzyme Secretion in Human Polymorphonuclear Leukocytes by Synthetic Diacylglycerols" (folder 1 of 3), 1985-1986
Box 9
"Differential Stimulation of the Respiratory Burst and Lysosomal Enzyme Secretion in Human Polymorphonuclear Leukocytes by Synthetic Diacylglycerols" (folder 2 of 3), 1985-1986
Box 9
"Differential Stimulation of the Respiratory Burst and Lysosomal Enzyme Secretion in Human Polymorphonuclear Leukocytes by Synthetic Diacylglycerols" (folder 3 of 3), 1985-1986
Box 9
"Mechanisms of Inflammation and Leukocyte Chemotaxis in the Rheumatic Diseases" in "The Medical Clinics of North America", 1985-1986
Box 9
"Receptor-Coupled Activation of Phosphoinositide-Specific Phospholipase C by a Nucleotide Regulatory Protein", 1985-1986
Box 9
"Suppression of the Respiratory Burst of Human Monocytes by a Synthetic Peptide Homologous to Envelope Proteins of Human and Animal Retroviruses", 1985-1986
Box 9
"Methods in Enzymology" Volume Manuscripts, 1985-1987
Box 9
"Role of a Guanine Nucleotide Regulatory Protein in the Polyphosphoinositide Pathway of Leukocyte Activation by Chemoattractant Receptors", 1985-1987
Box 39
"Role of a Guanine Nucleotide Regulatory Protein in the Polyphosphoinositide Pathway of Leukocyte Activation by Chemoattractant Receptors" [oversized], undated
Box 9
"The Cloned Hydrophilic Domain of Retroviral Protein P15E Supresses T-Cell Proliferation ", 1986
Box 9
"A Guanine Nucleotide Regulatory Protein Controls Polyphosphoinositide Metabolism, Ca2+ Mobilization, and Cellular Responses to Chemoattractants in Human Monocytes", 1986
Box 9
"N-Formyl-L-Methionyl-L-Leucyl-L-[3H] Phenylalanine Hydroylsis by a Plasma Membrane Metalloendoprotease of Human Polymorphonuclear Leukocyte: A Possible Mechanism for Temporal Perception of a Chemotactic Signal", 1986
Box 9
"Cecil Textbook of Medicine," 18th Edition Manuscripts, 1986-1987
Box 39
"Cecil Textbook of Medicine," 18th Edition Manuscripts [oversized], 1987
Box 9
"Leukocyte Activation by Chemoattractant Receptors: Roles of a Guanine Nucleotide Regulatory Protein and Polyphosphoinositide Metabolism", 1986-1987
Box 10
"Molecular Cloning of a New Human G Protein: Evidence for Two Gi[alpha]-Like Protein Families", 1986-1987
Box 10
"The Recombinant Hydrophilic Region of Murine Retroviral Protein P15E Inhibits Stimulated T-Lymphocyte Proliferation", 1986-1987
Box 39
"The Recombinant Hydrophilic Region of Murine Retroviral Protein P15E Inhibits Stimulated T-Lymphocyte Proliferation" [oversized], 1987
Box 10
"Role of a Guanine Nucleotide Regulatory Protein in the Activation of Phospholipase C by Different Chemoattractants", 1986-1987
Box 10
"Role of Chemotactic and Inflammatory Cytokines" in "Immunophysiology: The Role of Cells and Cytokines in Immunity and Inflammation", 1986-1987
Box 10
"Human Retrovirus-Related Synthetic Peptides Inhibit T Lymphocyte Proliferation", 1986-1988
Box 10
"Structure and Function of Monocytes and Macrophages" for "Arthritis and Allied Conditions," 11th Edition, 1986-1988
Box 10
"Chemoattractant Receptors and Signal Transduction Processes" (folder 1 of 2), 1987
Box 10
"Chemoattractant Receptors and Signal Transduction Processes" (folder 2 of 2), 1987
Box 10
"Chemoattractant-Induced Membrane Phenomena of Cells", 1987
Box 10
"Identification of a Novel Inositol Bisphosphate Isomer Formed in Chemoattractant Stimulated Human Polymorphonuclear Leukocytes", 1987
Box 10
"Isolation of GTP-Binding Proteins from Myeloid HL-60 Cells", 1987
Box 10
"The Formylpeptide Chemoattractant Receptor Copurifies with a GTP Binding Protein Containing a Distinct 40kDa Pertussis Toxin", 1987
Box 10
"Mapping of Immunogenic and Immunodominant Epitopes of Human Immunodeficiency Virus G120 with Env-Encoded Synthetic Peptides", 1987
Box 10
"A Model for Leukocyte Regulation by Chemoattractant Receptors: Roles of a Guanine Nucleotide Regulatory Protein and Polyphosphoinositide Metabolism", 1987
Box 10
"Molecular Cloning of a Novel Human GTP-Binding Protein and its Potential Role in Chemoattractant Stimulus-Response Coupling", 1987
Box 10
"Prokaryotic Expression of the P15E Component of a Human Endogenous Retrovirus and Development of Reactive Antiserum", 1987
Box 10
"Regulation of Inositol Phosphate Metabolism in Chemoattractant-Stimulated Human Polymorphonuclear Leukocytes: Definition of Distinct Dephosphorylation Pathways for IP3 Isomers", 1987
Box 10
"Regulation of Inositol Phospholipid and Inositol Phosphate Metabolism in Chemoattractant-Activated Human Polymorphonuclear Leukocytes", 1987
Box 10
"Review of the National Arthritis Advisory Board Symposium, 'Molecular Biology: Its Potential for Advancing Rheumatology Research'", 1987
Box 10
"Behcet's Disease - Provocative Clues", 1987-1988
Box 10
"Calcium Influx Stimulates a New Pathway for Sustained Diacylglycerol Production in Leukocytes Activated by Chemoattractants", 1987-1988
Box 39
"Calcium Influx Stimulates a New Pathway for Sustained Diacylglycerol Production in Leukocytes Activated by Chemoattractants" [oversized], circa 1988
Box 10
"Chemotaxis and Chemotactic Factors" and "Signal Transduction and Intracellular Messengers", 1987-1988
Box 10
"Preface" for "Rheumatic Disease Clinics of North America", 1987-1988
Box 10
"The Reserve Population of Formylpeptide Chemoattractant Receptors in Human Polymorphonuclear Leukocytes is not Coupled to a GTP-Binding Protein", 1987-1988
Box 11
"Retroviral Protein P15E and Tumorigenesis: Expression in Neither Required nor Sufficient for Tumor Development", 1987-1988
Box 11
"Signal Transduction in Cells Following Binding of Chemoattractants to Membrane Receptors" (folder 1 of 2), 1987-1988
Box 11
"Signal Transduction in Cells Following Binding of Chemoattractants to Membrane Receptors" (folder 2 of 2), 1987-1988
Box 11
"Analysis of Calcium Homeostasis in Activated Human Polymorphonuclear Leukocytes", 1988
Box 11
"Biochemical Changes in Leukocytes in Response to Chemoattractants" in "Methods in Enzymology, Volume 162", 1988
Box 11
"The Formylpeptide Chemoattractant Receptor Interacts with Two Distinct GTP-Binding Proteins", 1988
Box 11
"Identification of the Gi[alpha]-Subunits Encoded by Two Distinct cDNAs and Assignment of Gi[alpha] - 2 for Regulation of the Formylpeptide Chemoattractant Receptor", 1988
Box 11
"Immunopathology, Chapter 18", 1988
Box 11
"Molecular Cloning of Ligatin: A New Subclass of Peripheral Membrane Proteins", 1988
Box 11
"Production of a Retroviral P15E-Related Chemotaxis Inhibitor by Interleukin - 1 - Treated Endothelial Cells: A Possible Negative Feedback in the Regulation of the Vascular Response to Monokines", 1988
Box 11
"Characterization of G25K, a GTP-Binding Protein Containing a Novel Putative Nucleotide Binding Domain", 1988-1989
Box 11
"Evidence for Phosphatidylcholine (PC) - Specific Phospholipase D Activation in Stimulated Human Polymorphonuclear Leukocytes (PMNs)", 1988-1989
Box 11
"Mastoparan, A Wasp Venom Peptide, Identifies Two Discrete Mechanisms for Elevating Cytosolic Calcium and Inositol Trisphosphates in Human Neutrophils", 1988-1989
Box 11
"Multiple Chromatographic Forms of the Formylpeptide Chemoattractant Receptor and their Relationship to GTP-Binding Proteins", 1988-1989
Box 11
"Effects of CKS-17, A Synthetic Retroviral Envelope Peptide, on Cell-Mediated Immunity in Vivo: Immunosuppression, Immunogenicity, and Relation to Immunosuppressive Tumor Products", 1989
Box 11
"Identification of the Ral and Rac1 Gene Products, Low Molecular Mass GTP-Binding Proteins from Human Platelets", 1989
Box 11
"Inhibition of 5-Lypoxygenase Activation and Translocation in Human Neutrophils by Colchicine", 1989
Box 11
"Rac, a Novel Ras-Related Family of Proteins that Are Botulinum Toxin Substrates", 1989
Box 11
"Academic Health Centers: Their Role in Solving the Nation's Health Needs", 1993
Box 11
"Building a National Health Care Plan, Which Fosters Continuous Improvement", 1993
Box 11
"Health Care Reform and the Academic Health Center" (The White Paper: The Duke Response), 1994
Box 11
"Science, Technology, and Societal Goals", 1994
Box 11
"The Second Revolution in Undergraduate Medical Education", 1994
Box 11
"Development of Core Competencies: the First Step in Assessing the Adequacy of Medical School Education", 1995
Box 11
"Everybody Gets Something from Medicare - Their Doctors" and "Reform Could Ruin Teaching Hospitals", 1995
Box 11
"Maintaining Biomedical Research Excellence in a World of Challenged Public Funds", 1995
Box 11
"Model for a 21st Century Academic Health System", 1995
Box 11
"Refining Core Competencies During the Second Revolution in Undergraduate Medical Education", 1995
Box 11
"Redesigning Academic Medicine for the 21st Century", 1995-1996
Box 11
" 'Reform' Threatens N.C. Medical Schools: The Quality of Future Doctors Depends on Medicare Funding for Academic Hospitals and Clinics", 1995-1996
Box 11
"The Role of Subspeciality Programs in Departments of Internal Medicine in Markets with Major Penetration of Managed Care Networks", 1995-1996
Box 11
"Mind Body Medicine" and Draft Op-ed, circa 1996
Box 11
"The HMO Hazard: How the Quest for Short-term Profits May Undermine our Whole Health Care System" (The Washington Post), 1996-1997
Box 11
"Restructuring the Research Enterprise for the Future", 1996-1997
Box 12
"A Comprehensive Health System: It's Academic", 1997
Box 12
"The Integrated Academic Health System", 1997
Box 12
"Listening In on the Duke University Private Sector Conference", 1997
Box 12
"The Integrated Academic Health System: Have We Found a Solution for the Nation's Health?", 1998
Box 12
"Integrating Regional Health Systems", 1998
Box 12
"Academic Medicine Can Transform Health Care Through Clinical Research", 1999
Box 12
"Others Must Now Join Duke 'at the Table' ", 1999
Box 12
"Oversight Mechanisms for Clinical Research" (folder 1 of 2), 1999-2000
Box 12
"Oversight Mechanisms for Clinical Research" (folder 2 of 2), 1999-2000
Box 12
"Forging a New Circle of Medicine to Serve Society", 2000
Box 12
"Integrative Medicine: Bringing Medicine Back to Its Roots" (folder 1 of 2), 2000-2002
Box 12
"Integrative Medicine: Bringing Medicine Back to Its Roots" (folder 2 of 2), 2000-2002
Box 12
"Health Care Reform and the Academic Health Center - An Overview", undated
Box 12
"Human Gi Protein [alpha]-Subunit: Deduction of Amino Acid Structure from a Cloned cDNA", undated
Box 12
"Humoral and Bacterial Mediators of Inflammation", undated
Box 12
"Inhibition of Transmethylation Blocks the Production of Chemotactic Lymphokine by Human Mononuclear Leukocytes", undated
Box 12
"Leukocyte Chemoattraction by 1, 2-Diacylglycerol", undated
Box 12
"Lymphoma Models for B Cell Activation and Tolerance", undated
Box 12
Polarization Assay Study (in Japanese), undated
Box 12
"Requirement of Transmethylation Reactions for Eukaryotic Cell Chemotaxis", undated
Box 12
"Stimulus-Response Coupling Mechanisms", undated
Box 12
Collected Manuscript Diagrams, Charts, and Figures, undated
Box 12
Inactive Manuscripts, undated
Box 12

Writings by Others, 1980-2000

Subseries Scope and Contents: Contains manuscript drafts written by others and correspondence regarding the manuscripts. Most display annotations, comments, and edits likely contributed by Snyderman. Materials date from 1980 to 2000.

"Antiinflammatory Proteins Associated with Human and Murine Neoplasms", 1980-1986
Box 12
"Adult Respiratory Distress Syndrome", 1986
Box 12
"Emphysema: Proteinase-Antiproteinase Imbalance" and "Sweet's Syndrome and Pyoderma Gangrenosum: Models of Neutrophilic Dermatoses" for "Inflammation: Basic Principles and Clinical Correlates", 1987
Box 12
"Clinical Research: Ensuring Its Continuation and Growth", 2000
Box 12
"Ralph Snyderman, MD; CAM and the Role of the Academic Health Center", 2000
Box 12
Ben Lane's Detergent Manuscript, undated
Box 12
"Genes of the Complement System", undated
Box 12
"Gout: A Model of Crystal-Induced Inflammation", undated
Box 12
"Introduction to Clinical Immunology", undated
Box 12
"Macrophages as Destructive Cells in Host Defense", undated
Box 12
"Maturation, Development, and Distribution of Neutrophils and Eosinophils", undated
Box 12
"Molecular Mechanisms of Signal Transduction in Macrophages", undated
Box 12
"Myeloid Growth Factors", undated
Box 12
"Production of Retroviral P15E-Related Chemotaxis Inhibitor by IL-1 Treated Endothelial Cells: A Possible Negative Feedback in the", undated
Box 12
"Transcellular Metabolism of Eicosanoids in Hemostasis and Inflammation", undated
Box 12
Untitled Manuscript, undated
Box 12

Articles and Publications (by Snyderman), 1973-2000

Subseries Scope and Contents: Contains reprints or photocopies of published articles authored by Snyderman. The publications in this series do not have associated manuscript materials. Reprints and photocopies of articles with associated manuscript materials are located with their associated manuscript materials in the Manuscript Materials Subseries. Materials date from 1973 to 2000.

"Depression of Lymphocyte Transformation and Exacerbation of Behcet's Syndrome by Ingestion of English Walnuts", 1973
Box 12
"Chemotaxis of Mononuclear Leukocytes", 1974
Box 12
"Molecular Mechanisms of Inflammation", 1987
Box 12
"Keeping the Best Medicine", 1993
Box 12
"The HMO Hazard: New Fears that the Drive for Short-term Profits May Undermine the Health Care System", 1997
Box 12
"The Emerging Health Care Crisis in the City of Medicine", 2000
Box 12
"Interactions of the Complement System with Endotoxic Lipopolysaccharides: Complement-Membrane Interactions and Endotoxic-Induced Inflammation", undated
Box 12

2. Research, 1899-1989

Series Scope and Contents: Contains articles, reprints, research notes, and research data. The articles and reprints in this series were not written by Snyderman. Many contain highlighted sections, underlining, annotations, and corresponding notes. Materials date from 1899 to 1989.

Subject Files, 1899-1989

Subseries Scope and Contents: Contains research articles arranged by subject with some highlighted sections, underlining, annotations, and corresponding notes. Many of the articles are numbered, with like numbers grouped together in the same research subject file. It is unclear, however, to exactly what the numbering corresponds. The collected publications which are not organized into subject files do not exhibit this numbering; the numbers may represent a research organization system imposed by Snyderman and/or his staff. Materials range in date from 1899 to 1989.

Acute Phase Reactants, 1982-1984
Box 13
Adhesion Proteins, 1985
Box 13
Adrenergic Receptors, 1978
Box 13
Allergy Study Notes, undated
Box 13
Angiodysplasia, 1976-1979
Box 13
Anti-Globulins Including C'19, 1959-1985
Box 13
Antigen - Antibody Reactions in Serum (folder 1 of 3), 1955-1971
Box 13
Antigen - Antibody Reactions in Serum (folder 2 of 3), 1955-1971
Box 13
Antigen - Antibody Reactions in Serum (folder 3 of 3), 1955-1971
Box 13
Antinuclear Antibodies, 1980-1985
Box 20
Antitrypsin, 1974
Box 13
Arachidonic Acid Metabolites, 1980-1986
Box 13
Arthritis, 1972-1975
Box 13
Atopy, 1975-1984
Box 13
Bacterial Products, 1969-1976
Box 13
Behcet's Syndrome (folder 1 of 2), 1963-1985
Box 13
Behcet's Syndrome (folder 2 of 2), 1963-1985
Box 13
Biochemistry - General, undated
Box 13
Biomembranes, 1982
Box 13
Blood Disorders, 1977
Box 13
Blood Group Factors, 1958-1967
Box 13
Bone Absorption, 1966-1982
Box 20
Calmodulin, Calcium, 1983-1984
Box 13
Cell Lines, 1982
Box 13
Cell Sorters, 1980
Box 13
Cellular Immunity (folder 1 of 2), 1964-1975
Box 20
Cellular Immunity (folder 2 of 2), 1964-1975
Box 20
Chemoattractants (Chemotaxis Factors), 1977-1980
Box 13
Chemotactic-Factor Induced Events, 1977-1978
Box 13
Chemotaxis - Bacterial, 1977-1984
Box 13
Chemotaxis - Clinical (folder 1 of 2), 1969-1982
Box 13
Chemotaxis - Clinical (folder 2 of 2), 1969-1982
Box 13
Chemotaxis - Complement (folder 1 of 2), 1961-1985
Box 13
Chemotaxis - Complement (folder 2 of 2), 1961-1985
Box 13
Chemotaxis - Cytoskeleton, 1964-1982
Box 13
Chemotaxis - Defective PMN, 1977-1980
Box 13
Chemotaxis - Drug Effects, 1975-1983
Box 13
Chemotaxis - Fibroblast, undated
Box 20
Chemotaxis - General, 1973-1985
Box 13
Chemotaxis - Ion Events, 1984
Box 13
Chemotaxis - Lymphocyte, 1969-1982
Box 13
Chemotaxis - Methods, 1975-1986
Box 13
Chemotaxis - Methylation, 1982
Box 14
Chemotaxis - Physiology, 1975-1984
Box 14
Chemotaxis - Receptors (folder 1 of 2), 1976-1985
Box 14
Chemotaxis - Receptors (folder 2 of 2), 1976-1985
Box 14
Chromatography (folder 1 of 2), 1964-1968
Box 14
Chromatography (folder 2 of 2), 1964-1968
Box 14
Chronic Granulomatous Disease (CGD), 1978
Box 14
Clinical - General (folder 1 of 2), 1952-1983
Box 14
Clinical - General (folder 2 of 2), 1952-1983
Box 14
Coagulopathy, 1968-1980
Box 14
Complement - Alternative Pathway, 1968-1985
Box 14
Complement - Anaphylatoxin (folder 1 of 2), 1959-1981
Box 14
Complement - Anaphylatoxin (folder 2 of 2), 1959-1981
Box 14
Complement - C3 & C5 (folder 1 of 2), 1964-1985
Box 14
Complement - C3 & C5 (folder 2 of 2), 1964-1985
Box 14
Complement - Clinical (folder 1 of 2), 1963-1986
Box 14
Complement - Clinical (folder 2 of 2), 1963-1986
Box 14
Complement - Deficiencies, 1978-1985
Box 14
Complement - Duke Clinical Studies, 1966-1976
Box 14
Complement - Duke Clinical Studies [oversized], undated
Box 39
Complement - Early Components (folder 1 of 2), 1961-1981
Box 14
Complement - Early Components (folder 2 of 2), 1961-1981
Box 15
Complement - Hemolytic Mechanisms (folder 1 of 2), 1963-1986
Box 15
Complement - Hemolytic Mechanisms (folder 2 of 2), 1963-1986
Box 15
Complement - Immune Adherence and Phagocytosis, 1956-1980
Box 15
Complement - Mechanisms, 1964-1972
Box 15
Complement - Methods for Preparation, 1965-1980
Box 15
Complement - Miscellaneous (folder 1 of 3), 1949-1986
Box 15
Complement - Miscellaneous (folder 2 of 3), 1949-1986
Box 15
Complement - Miscellaneous (folder 3 of 3), 1949-1986
Box 15
Complement - Viruses, 1976-1980
Box 15
Contractile Proteins, 1975-1979
Box 15
Cyclic AMP & Medlars, 1965-1984
Box 15
Cytoskeleton, 1981
Box 15
Data for Papers, 1969-1973
Box 15
Data for Papers [oversized], undated
Box 39
Dermato-Polymyositis, 1982-1985
Box 15
Dermatological Inflammation, 1972-1980
Box 15
Endotoxin - General (folder 1 of 2), 1955-1979
Box 15
Endotoxin - General (folder 2 of 2), 1955-1979
Box 15
Endotoxin - Resistance, 195501985
Box 15
Endotoxin - Shock, 1961-1972
Box 15
G Protein (folder 1 of 4), 1978-1989
Box 15
G Protein (folder 2 of 4), 1978-1989
Box 15
G Protein (folder 3 of 4), 1978-1989
Box 16
G Protein (folder 4 of 4), 1978-1989
Box 16
Glomerulonephritis, 1965-1973
Box 16
Goodpasture's Syndrome, 1967-1974
Box 16
Gout - Pseudogout, 1977
Box 16
Gout & Crystal Arthritis, 1975-1980
Box 16
Haemolysins, 1899-1901
Box 16
Hageman Factor, 1958-1968
Box 16
Hematology, 1961-1969
Box 20
Histamine, IgE, 1968-1978
Box 16
Idiotypes, 1971-1981
Box 16
Immune Complexes, 1976-1983
Box 16
Immune Deficiency Diseases (folder 1 of 3), 1958-1983
Box 16
Immune Deficiency Diseases (folder 2 of 3), 1958-1983
Box 16
Immune Deficiency Diseases (folder 3 of 3), 1958-1983
Box 16
Immune Deficiency States, 1960-1979
Box 16
Immune Mechanisms (folder 1 of 2), 1957-1980
Box 16
Immune Mechanisms (folder 2 of 2), 1957-1980
Box 16
Immunogenetics - HLA, IA, 1975-1980
Box 16
Infectious Arthritis, 1971-1983
Box 16
Infectious Diseases, 1971-1979
Box 16
Inflammation - General, 1978-1985
Box 16
Interferons, 1984-1985
Box 16
Kawasaki Syndrome, 1981-1983
Box 16
Lab Work (folder 1 of 2), 1981-1988
Box 16
Lab Work (folder 2 of 2), 1981-1988
Box 16
Levamisole, 1980
Box 16
Levamisole - Agranulocytosis, 1974-1977
Box 16
Levamisole - Immunology, 1974-1976
Box 16
Levamisole - Skin, 1974-1975
Box 16
Lipids, 1961-1982
Box 16
Lymphocyte Mechanisms, 1972-1983
Box 17
Lymphokines, 1964-1985
Box 17
Lymphomas, 1984
Box 17
Macrophages (folder 1 of 2), 1970-1985
Box 17
Macrophages (folder 2 of 2), 1970-1985
Box 17
Major Histocompatibility Complex (MHC), 1980
Box 17
Maternal-Fetal Relationships, 1968-1976
Box 17
Mechanisms of Immunoregulation, 1977-1979
Box 17
Medlars Citation Lists (folder 1 of 2), 1980-1985
Box 17
Medlars Citation Lists (folder 2 of 2), 1980-1985
Box 17
Membrane Physiology, 1972-1982
Box 17
Methotrexate - Pneumonia, 1976-1983
Box 17
Methylation, 1975-1981
Box 17
Miscellaneous, 1968-1985
Box 20
Molecular Genetics, 1973-1985
Box 17
Monoclonal Antibodies, 1979-1981
Box 17
Natural Killer (NK) Cells, undated
Box 17
Neoplasia and Lymphocytes, 1969-1985
Box 17
Neoplasia and Macrophages (folder 1 of 2), 1967-1979
Box 17
Neoplasia and Macrophages (folder 2 of 2), 1967-1979
Box 17
Neoplasia - Miscellaneous, 1970-1984
Box 17
Neovascularization, 1975
Box 17
Nonimmunogenic Enzymes, 1974-1977
Box 17
Nucleotides, 1978-1985
Box 17
Oncogenes, 1979-1985
Box 17
Oxygen-Radicals, 1978-1985
Box 18
Periodontal Disease, 1969-1985
Box 18
Phagocyte Dysfunction, 1964-1978
Box 18
Pheresis, 1974-1985
Box 18
Phosphodiesterase, 1982-1983
Box 18
Phospholipases, 1981-1985
Box 18
Plasmacytomas and Hybridomas, undated
Box 18
Platelets - Endotoxin (Schwartzman) (folder 1 of 3), 1951-1972
Box 20
Platelets - Endotoxin (Schwartzman) (folder 2 of 3), 1951-1972
Box 20
Platelets - Endotoxin (Schwartzman) (folder 3 of 3), 1951-1972
Box 20
Polymorphonuclear Leukocytes (folder 1 of 2), 1955-1977
Box 18
Polymorphonuclear Leukocytes (folder 2 of 2), 1955-1977
Box 18
Post Translational Modification of Proteins, 1972-1981
Box 18
Preparations (folder 1 of 2), 1951-1978
Box 18
Preparations (folder 2 of 2), 1951-1978
Box 18
Progressive Systemic Sclerosis (PSS), 1971-1984
Box 18
Properdin, 1956-1974
Box 18
Prostaglandins (folder 1 of 2), 1968-1983
Box 18
Prostaglandins (folder 2 of 2), 1968-1983
Box 18
Protein Kinase / Phosphatase, 1982-1986
Box 18
Psoriatic Arthritis, 1978
Box 18
Purines and Immunology, 1972-1977
Box 18
Receptors (folder 1 of 2), 1975-1983
Box 18
Receptors (folder 2 of 2), 1975-1983
Box 18
Receptors - General, 1977-1984
Box 18
Relapsing Polychondritis (folder 1 of 2), 1975-1985
Box 18
Relapsing Polychondritis (folder 2 of 2), 1975-1985
Box 18
Retroviruses and Retroviral, 1981-1985
Box 20
Rheumatic Diseases - General, 1978-1985
Box 18
Rheumatic Fever and Juvenile Rheumatoid Arthritis, 1968-1982
Box 18
Rheumatoid Arthritis (folder 1 of 3), 1964-1986
Box 19
Rheumatoid Arthritis (folder 2 of 3), 1964-1986
Box 19
Rheumatoid Arthritis (folder 3 of 3), 1964-1986
Box 19
SLE / Animal Models, 1984
Box 19
SRS, 1960-1976
Box 20
Sarcoidosis, 1976
Box 19
Schwartzmann Reaction, 1973
Box 19
Scleroderma, 1977-1986
Box 19
Secretion - Lysosomal Enzymes, 1965-1985
Box 19
Septic Arthritis, 1974-1985
Box 19
Sjogren's Syndrome, 1976-1983
Box 19
Spondylo Arthritis, 1981-1984
Box 19
Synthetic Peptides, 1982-1984
Box 19
Systemic Lupus Erythematosus (SLE) (folder 1 of 3), 1968-1986
Box 19
Systemic Lupus Erythematosus (SLE) (folder 2 of 3), 1968-1986
Box 19
Systemic Lupus Erythematosus (SLE) (folder 3 of 3), 1968-1986
Box 19
Thymus, 1963-1975
Box 19
Tolerance, 1966-1978
Box 19
Transfer Factor, 1970-1976
Box 19
Tumor Immunology, 1975-1981
Box 19
Unidentified, 1978-1979
Box 19
Unidentified, 1980-1985
Box 19
Urticaria, 1977-1985
Box 19
Vasculitis (folder 1 of 2), 1968-1985
Box 19
Vasculitis (folder 2 of 2), 1968-1985
Box 19
Vasoactive Peptides, 1958-1974
Box 19
Virus (folder 1 of 2), 1968-1975
Box 19
Virus (folder 2 of 2), 1968-1975
Box 19
Viruses, 1971-1983
Box 21
Viruses and Immunity, 1969-1982
Box 21

Collected Publications, 1900-1989

Subseries Scope and Contents: Includes collected publications that were not grouped according to subject. Some publications display annotations, highlighted sections, and associated notes. The specifically named journals in the subseries, such as "Immunology Today" and "The Medical Letter," do not exhibit full runs. Materials date from 1900 to 1989.

"Approved Drug Products and Legal Requirements," Ninth Edition, 1989
Box 21
"Clinical Trends in Rheumatology", 1970-1977
Box 21
"Immunology Today", 1981-1982
Box 21
"Immunology Today", 1983
Box 21
"Immunology Today", 1984
Box 21
"Immunology Today", 1985
Box 21
"Immunology Today", 1986
Box 21
"The Medical Letter", 1980
Box 21
"The Medical Letter", 1981
Box 21
"The Medical Letter", 1982
Box 21
"The Medical Letter", 1984
Box 21
"The Medical Letter", 1985
Box 21
"The Medical Letter", 1986
Box 21
"The Medical Letter", 1987
Box 21
"New Developments in Biotechnology", 1988
Box 21
Publications, 1900-1910
Box 21
Publications, 1957
Box 21
Publications, 1973-1975
Box 21
Publications, 1976-1979
Box 21
Publications, 1980-1981
Box 21
Publications, 1982
Box 21
Publications, 1983
Box 21
Publications (folder 1 of 2), 1984
Box 21
Publications (folder 2 of 2), 1984
Box 21
Publications (folder 1 of 3), 1985
Box 22
Publications (folder 2 of 3), 1985
Box 22
Publications (folder 3 of 3), 1985
Box 22
Publications (folder 1 of 4), 1986
Box 22
Publications (folder 2 of 4), 1986
Box 22
Publications (folder 3 of 4), 1986
Box 22
Publications (folder 4 of 4), 1986
Box 22
Publications, 1987-1988
Box 22
Publications (folder 1 of 2), undated
Box 22
Publications (folder 2 of 2), undated
Box 22

3. Professional Papers, 1985-2005

Series Scope and Contents: Contains records related to Snyderman's professional career. Such materials include professional correspondence, business records from Snyderman's positions as Chancellor for Health Affairs and Dean of the School of Medicine and Chancellor Emeritus at Duke, memoranda, correspondence, conference itineraries and programs, and other documents related to Snyderman's participation and membership in various professional societies and committees. Materials date from 1985 to 2005.

Affiliations and Memberships, 1985-2002

Subseries Scope and Content: Contains memoranda, correspondence, conference programs, proceedings, planning materials, and other documents related to Snyderman's participation and membership in various professional societies, editorial boards, and committees. Materials date from 1985 to 2002.

Ad Hoc Group for Medical Research, National Institute of Arthritis and Musculoskeletal Skin Diseases, 1986-1987
Box 22
American Federation for Clinical Research (AFCR), 1987
Box 22
American Rheumatism Association (ARA), 1986
Box 22
American Rheumatism Association (ARA), 1987
Box 22
American Rheumatism Association (ARA), 1988
Box 22
American Society for Clinical Investigation (ASCI), 1987
Box 22
American Society for Clinical Investigation (ASCI), 1988
Box 22
American Society for Clinical Investigation (ASCI), undated
Box 22
Arthritis Foundation, 1986
Box 22
Arthritis Foundation, 1987
Box 22
Arthritis Foundation, 1987-1988
Box 22
Association of American Medical Colleges (AAMC), 1987
Box 22
Association of American Medical Colleges (AAMC), 1988
Box 22
Association of American Medical Colleges (AAMC) - Clinical Research Task Force, 1999-2000
Box 23
Association of American Medical Colleges (AAMC) - Clinical Research Task Force, 2000
Box 23
Association of American Medical Colleges (AAMC) - Council of Deans (COD) Administrative Board, 2001
Box 23
Association of American Medical Colleges (AAMC) - Executive Committee, 2001
Box 23
Association of American Medical Colleges (AAMC) - Investment Committee, 2001
Box 23
Association of American Physicians (AAP), 1987-1989
Box 23
Association of American Physicians (AAP), 2001-2002
Box 23
Cardiorenal Advisory Committee, 1987
Box 23
"Clinical and Diagnostic Laboratory Immunology" Editorial Board, 1994-2000
Box 23
Federation of American Societies for Experimental Biology and Guest Societies (FASEB), 1987
Box 23
Federation of American Societies for Experimental Biology and Guest Societies (FASEB), 1988
Box 23
Federation of American Societies for Experimental Biology and Guest Societies (FASEB), 1989
Box 23
Institute of Medicine (IOM), 1988
Box 23
"Journal of Clinical Investigation" Committee, 1988
Box 23
"Journal of Clinical Investigation" Committee, 1989
Box 23
National Arthritis Advisory Board (NAAB), 1985
Box 23
National Arthritis Advisory Board (NAAB), 1986
Box 23
National Arthritis Advisory Board (NAAB) (folder 1 of 3), 1987
Box 23
National Arthritis Advisory Board (NAAB) (folder 2 of 3), 1987
Box 23
National Arthritis Advisory Board (NAAB) (folder 3 of 3), 1987
Box 23
National Arthritis Advisory Board (NAAB) (folder 1 of 4), 1988
Box 23
National Arthritis Advisory Board (NAAB) (folder 2 of 4), 1988
Box 23
National Arthritis Advisory Board (NAAB) (folder 3 of 4), 1988
Box 23
National Arthritis Advisory Board (NAAB) (folder 4 of 4), 1988
Box 24
National Arthritis Advisory Board (NAAB), undated
Box 24
National Arthritis Advisory Board (NAAB) - Molecular Biology Conference (folder 1 of 3), 1985-1987
Box 24
National Arthritis Advisory Board (NAAB) - Molecular Biology Conference (folder 2 of 3), 1985-1987
Box 24
National Arthritis Advisory Board (NAAB) - Molecular Biology Conference (folder 3 of 3), 1985-1987
Box 24

Business Records, 1987-2005

Subseries Scope and Contents: Contains correspondence, memos, reports, itineraries, and budget materials from Snyderman's time as Chancellor for Health Affairs and Dean of the School of Medicine and Chancellor Emeritus. Materials date from 1987 to 2005.

Access Restrictions: Series contains Medical Center Administrative records. For further information consult with the Medical Center Archivist.

"The Academic Health Center Enters the Health Care Revolution" Thought Piece, 14-Aug-95
Box 24
Chancellor Emeritus Office Operating Budget, July 2004 - June 2005
Box 24
Correspondence, 1988
Box 24
Correspondence (folder 1 of 2), 1989
Box 24
Correspondence (folder 2 of 2), 1989
Box 24
Internal Memos, 1989
Box 24
Itineraries, 1989
Box 24
Letters to DUMC Faculty, 1999-2000
Box 24
Reports: Development of the Basic Sciences at Duke University Medical Center Report and Materials, 1987-1988
Box 24
Reports: Report to the Board of Governors of the Consolidated University of North Carolina Update: Primary Care Education Plan, Duke University School of Medicine, 1-Apr-96
Box 24
Reports: "Toward a Model Workplace", 29-Jul-93
Box 24

Other, 1985-1994

Subseries Scope and Contents: Contains other materials that relate to Snyderman's professional career at Duke including correspondence, reports, and administrative materials like Duke University Division of Rheumatology and Immunology Letterheads and a reprint order form. Materials date from 1985 to 1994.

Article and Manuscript Review Correspondence, 1986-1987
Box 24
Correspondence, 1985-1986
Box 24
Duke Institutional Review Board (IRB) Materials, 1987-1989
Box 24
Duke University Division of Rheumatology and Immunology Letterhead, undated
Box 24
"Innovations in Rheumatology at Duke University Medical Center", Nov-88
Box 24
Macrophage Function Laboratory Progress Report, 1987
Box 24
Reprint Order Form, 1994
Box 24

4. Presentations and Talks, 1988-2003

Series Scope and Contents: Contains copies of presentation slides, notes, outlines, other talk and presentation preparation materials, correspondence regarding events at which Snyderman presented, and some travel planning material for talks which required Snyderman to travel. Some talks and presentations in this series have related travel materials housed in the Travel Files Series. Folders are arranged in chronological order by presentation date. Materials date from 1988 to 2003.

Access Restrictions: Series contains Medical Center Administrative records and Records of the Board of Trustees of the Duke University Medical Center. For further information consult with the Medical Center Archivist.

Hippocratic Oath Ceremonies, Duke University, Durham, NC, 1988-1994
Box 24
Hippocratic Oath Ceremonies, Duke University, Durham, NC, 1995-1996
Box 24
Hippocratic Oath Ceremonies, Duke University, Durham, NC, 1997-1998, undated
Box 24
School of Medicine Orientations, Duke University, Durham, NC (August 13, 1997; August 12, 1998), 1996-1998
Box 24
Dean's Council, Duke University, Durham, NC (January 5, 1998), 1998
Box 24
"Institute for Human Genetics at Duke University," Transforming Gift Presentation (January 15, 1998), 1998
Box 24
Board of Trustees, Executive Committee / Trustee Committee, Duke University Health System (January 16, 1998), 1998
Box 24
MedPAC Presentation (January 20, 1998), 1998
Box 24
Presentation to Alamance Regional Medical Center (January 21, 1998), 1998
Box 24
Academic Council Meeting, Duke University, Durham, NC (January 22, 1998), 1997-1998
Box 24
School of Nursing Advisory Board, Duke University, Durham, NC (January 24, 1998), 1998
Box 24
Duke University Health System Retreat (January 30, 1998), 1998
Box 24
Florida Talks (February 6-7, 1998), 1998
Box 24
Healthy Heart, Healthy Life: A Focus on Women - A Women and Heart Disease Conference, Research Triangle Park, NC (February 14, 1998), 1998
Box 24
"Duke's Commitment to Durham Regional and Community Physicians," Durham Regional Medical Staff Presentation (February 24, 1998), 1998
Box 24
Board of Trustees (February 28, 1998), 1998
Box 24
Board of Trustees Retreat (March 1, 1998), 1998
Box 24
Clinical Chair Meeting (March 3, 1998), 1998
Box 24
Princeton University Talk, Princeton, NJ (March 9, 1998), 1998
Box 24
"Chemotaxis of Leukocytes: The Cells, the Signals, and the Receptors," Proctor & Gamble Life Sciences and Biotechnology Symposium (March 12, 1998), 1998
Box 24
Duke Private Sector Conference (March 16, 1998), 1998
Box 24
West Palm Beach Forum (March 20, 1998), 1998
Box 24
AAMC Council of Deans Spring Meeting (April 4, 1998), 1998
Box 24
The Children Health Center Tip-off, Duke University, Durham, NC (May 1, 1998), 1998
Box 24
Rheumatology Awards Dinner, Searle Center, Duke University, Durham, NC (May 5, 1998), 1998
Box 24
"Long Range Plan, 1998," Presented at MedPAC (May 5, 1998), Faculty Meeting (May 5, 1998), and TC DUHS Trustee Meeting (May 7-8, 1998), May 1998
Box 24
Machemer Dinner (May 7, 1998), 1998
Box 25
Medical Faculty Wives Luncheon, Washington Duke Inn, Durham, NC (May 7, 1998), 1998
Box 25
Board of Trustees (May 16, 1998), 1998
Box 25
"Integrated Health Delivery Systems: the Role of Academic Health Centers" - Argentina Talk (May 19, 1998), 1998
Box 25
Board of Visitors Presentation (June 6, 1998), 1998
Box 25
DUHS BOT Presentation (June 19, 1998), 1998
Box 25
PDC Partnership Meeting (July 7, 1998), 1998
Box 25
Special MedPAC Meeting, Duke University, Durham, NC (August 12, 1998), 1998
Box 25
Trustee Committee for the Duke University Health System, Duke University, Durham, NC (August 21, 1998), 1998
Box 25
Clinical Chairs Meeting, Duke University, Durham (September 1, 1998), 1998
Box 25
OPS Presentation (September 17, 1998), 1998
Box 25
Symposium in Cellular & Biosurface Engineering, Seale Center, Duke University, Durham, NC (September 28, 1998), 1998
Box 25
Board of Trustees and Duke University Health System Orientation, September 1998
Box 25
"Field of Dreams" Talk, DUMC Campaign Kickoff Event, Durham Bulls Athletic Park, Durham, NC (October 2, 1998), 1998
Box 25
Genetics Symposium, Duke University, Durham, NC (October 3, 1998), 1998
Box 25
"The Duke Endowment" (October 5, 1998), 1998
Box 25
MedPAC Presentation (October 6, 1998), 1998
Box 25
Genomic Imprinting Symposium, Washington Duke Hotel, Durham, NC (October 8, 1998), 1998
Box 25
Stedman Nutrition Center Board (October 14, 1998), 1998
Box 25
Wake County Medical Society Talk (October 15, 1998), 1998
Box 25
Robertson Dinner (October 21, 1998), 1998
Box 25
Arthritis Foundation Lifetime Achievement Award Dinner for Dr. Gertrude B. Elion (October 22, 1998), 1998-1999
Box 25
Durham Rotary Club - United Methodist Retirement Homes (UMRH) Meeting (October 26, 1998), 1998
Box 25
Cardiology Associates Faculty Meeting, Duke University, Durham, NC (October 27, 1998), 1998
Box 25
Healthcare Costs and Innovation Presentation, Duke University, Durham, NC (October 27, 1998), 1998
Box 25
Board of Trustees Presentation (October 30, 1998), 1998
Box 25
Private Diagnostic Clinic (PDC) Administrative Board Meeting, Duke University, Durham, NC (November 4, 1998), 1998
Box 25
Quality and Accountability Conference, Ellwood (November 13, 1998), November 13, 1998
Box 25
Wakeman Award Reception, Searle Center, Duke University, Durham, NC (November 13, 1998), 1998
Box 25
Pediatric Faculty Meeting, Duke University, Durham, NC (November 18, 1998), 1998
Box 25
Surgery Faculty Meeting, Duke University, Durham, NC (November 18, 1998), 1998
Box 25
Business Managers Meeting, Medical Center Board Room, Durham, NC (November 19, 1998), 1998
Box 25
Herbert A. Saltzman Retirement Reception, University Club, Durham, NC (December 1, 1998), 1998
Box 25
Lincoln-Duke Urgent Care Center Ribbon-Cutting Ceremony, Lincoln Community Health Center, Durham, NC (December 1, 1998), 1998
Box 25
Josiah C. Trent Professorship Celebration, Bryan University Center, Duke University, NC (December 2, 1998) (folder 1 of 2), 1998
Box 25
Josiah C. Trent Professorship Celebration, Bryan University Center, Duke University, NC (December 2, 1998) (folder 2 of 2), 1998
Box 25
Department of Medicine Faculty Meeting, Duke University, Durham, NC (December 14, 1998), 1998
Box 25
Medical Center Faculty Meeting, Duke University, Durham, NC (December 17, 1998), 1998
Box 25
Martin Luther King, Jr. Celebration, Duke University, Durham, NC (January 19, 1999), 1999
Box 25
OB/GYN Faculty Meeting (January 20, 1999), 1999
Box 25
Private Diagnostic Clinic (PDC) Administrative Board (January 20, 1999), 1999
Box 25
Duke University Health System Strategic Planning Meeting (January 30, 1999), 1999
Box 25
MedPAC (February 2, 1999), 1999
Box 25
"The Role of Alternative Medicine in the Academic Health Center," Humanities in Medicine Lecture Series, Duke University, Durham, NC (March 10, 1999), 1998-1999
Box 25
Board of Visitors, Duke University Health System (March 11, 1999), 1999
Box 25
Benenson Lunch and Palm Beach Forum, Palm Beach, FL (March 19-20, 1999), 1999
Box 25
Duke University Faculty Noon Group, Duke University, Durham, NC (March 12, 1999), 1998-1999
Box 25
Medical School Faculty Wives and the Nearly New Shoppe Luncheon, Durham, NC (March 25, 1999), 1999
Box 25
Board of Directors Executive Committee (April 9, 1999), 1999
Box 25
Physician Executive Leadership Program, Duke University, Durham, NC (April 5, 1999), 1998-1999
Box 25
Women-In-Action Founder's Award Banquet, Durham, NC (April 15, 1999), 1999
Box 25
"Medicine for the New Millennium: Integrating Mind, Body, and Spirit in Health Care," Duke University Alumni Panel, Duke University, Durham, NC (April 16, 1999), 1999
Box 25
AAMC Council of Deans (April 19, 1999), 1999
Box 25
Cluster Groups / Steve Sloate AHC Marketing Group (April 22, 1999), 1999
Box 25
MedPAC (May 5, 1999), 1999
Box 25
Spring Faculty Meeting, Duke University, Durham, NC (May 6, 1999), 1999
Box 25
Maimonides Ceremony, Duke University, Durham, NC (May 15, 1999), 1999
Box 25
"Transformation of DUMC," Duke University Board of Trustees (May 15, 1999), 1999
Box 25
Board of Trustees (June 10, 1999), 1999
Box 25
"The Duke Endowment" (June 18, 1999), 1999
Box 25
"Engineering: Education to Serve the World," American Society for Engineering Education (ASEE) Conference, Charlotte, NC (June 21, 1999), 1999
Box 25
"Integrated Health Delivery Systems," American Society of Echocardiography Retreat, Durham, NC (July 29, 1999), 1999
Box 25
Integrative Medicine (July 31, 1999 - August 1, 1999), 1999
Box 25
DCCC Forum, Linville, NC (August 9, 1999), 1999
Box 25
Administrative Council Retreat, Asheville, NC (August 15-17, 1999), 1999
Box 25
Board of Trustees (August 20, 1999), 1999
Box 25
P&G Policy Management Council (September 9, 1999), 1999
Box 25
AAMC Clinical Research Task Force (September 10, 1999), 1999
Box 25
MedPAC (September 29, 1999), 1999
Box 25
Board of Trustees (September 30, 1999), 1999
Box 25
Board of Visitors (October 1, 1999), 1999
Box 25
AAMC Annual Meeting, Council of Deans, Washington, D.C. (October 25, 1999), 1999
Box 25
Vancouver Forum, Vancouver, Canada (October 30, 1999), 1999
Box 25
Patient Resource Managers Orientation, Duke University, Durham, NC (November 3, 1999), 1999
Box 25
Medical Alumni Weekend, Washington Duke Inn, Durham, NC (November 5, 1999), 1999
Box 25
Duke Medical Alumni Reception, Denver, CO (November 8, 1999), 1999
Box 25
A.J. Kauvar Lecture, University of Colorado Health Sciences Center, Denver, CO (November 9, 1999), 1998-1999
Box 25
"The Academic Health Center: Opportunities & Challenges," Project Medical Education, DUMC, Durham, NC (November 11, 1999), 1999
Box 25
"Academic Medical Centers, Present and Future," Physician Executive Leadership Program, Duke University, Durham, NC (November 18, 1999), 1999
Box 25
Duke University Health System Board of Directors (December 2, 1999), 1999
Box 25
Duke University Board of Trustees (December 4, 1999), 1999
Box 25
"AAMC Task Force on Clinical Research," Joint Conference Committee Meeting (January 6, 2000), 1999-2000
Box 25
DUMC Business Managers Meeting (January 6, 2000), 2000
Box 25
AAMC Clinical Research Task Force (CRTF) Report / Press Conference (January 13, 2000), 2000
Box 25
School of Nursing Reappointment Reception, Duke University, Durham, NC (January 21, 2000), 1999-2000
Box 25
Patient Resource Managers (January 25, 2000), 2000
Box 25
"Currents Shaping the Future of Healthcare," The Forum Club, FL (January 28, 2000), 2000
Box 25
Board of Trustees (February 25, 2000), 2000
Box 25
Project Medical Education Luncheon, Washington, D.C. (March 1, 2000), 2000
Box 25
"Medicine in the New Millennium," Palm Beach Forum, FL (March 6, 2000), 2000
Box 25
Medical Alumni Council Meeting, Washington Duke Inn, Durham, NC (March 17, 2000), 2000
Box 25
Medical Families Weekend, Duke University, Durham, NC (March 18, 2000), 2000
Box 25
"Academic Health Systems in Transition," Duke Private Sector Conference (March 20, 2000), 2000
Box 25
AAMC Council of Deans Spring Meeting, Rio Grande, Puerto Rico (April 15, 2000), 2000-2002
Box 25
Duke Clinical Research Institute (DCRI) Faculty Meeting (April 24, 2000), 1999-2000
Box 25
Clinical Chairs Retreat (May 4, 2000), 2000
Box 25
"The Role of Clinical Investigation in the Transformation of Health Care," Doris Duke Foundation, Warrenton, VA (May 7, 2000), 2000
Box 26
"DUHS: Positioning Success in a Rapidly Changing Healthcare Environment," Physician Executive Leadership Program, Duke University, Durham, NC (May 9, 2000), 2000
Box 26
Spring Faculty Meeting, Duke University, Durham, NC (May 10, 2000), 2000
Box 26
Duke University Health System Board of Directors Meeting (May 11, 2000), 2000
Box 26
Board of Trustees Dinner Honoring "Ike" Robinson (May 12, 2000), 2000
Box 26
Medical Center Affairs Committee (May 12, 2000), 2000
Box 26
Board of Trustees, Duke University (May 13, 2000), 2000
Box 26
McGovern-Davison Children's Health Center (CHC) Dedication, Durham, NC (May 13, 2000), 2000
Box 26
Maimonides Ceremony, Duke University, Durham, NC (May 13, 2000), 2000
Box 26
Board of Visitors, Duke University Medical Center (June 1, 2000), 2000
Box 26
"Class of 2004 Welcome and Orientation," Duke University, Durham, NC (August 9, 2000), 2000
Box 26
White Coat Ceremony, Duke University, Durham, NC (August 9, 2000), 2000
Box 26
"An Overview of the Duke University Health System," Fuqua Health Sector Management Program, Duke University, Durham, NC (August 10, 2000), 2000
Box 26
Medtronic CEO Summit, Minneapolis, MN (August 23, 2000), 2000
Box 26
Nannerl O. Keohane Retreat (August 28, 2000), 2000
Box 26
Talking Points - Durham Regional Hospital / Lincoln Community Health Center (September 6, 2000), 2000
Box 26
Trustee Orientation, Duke University, Durham, NC (October 5, 2000), 2000
Box 26
CEO's Report, Duke University Health System Board of Directors (October 6, 2000), 2000
Box 26
"Investing in Clinical Research," Academic Health Centers' (AHC) Clinical Research Forum, Arlington, VA (October 18, 2000), 1999-2000
Box 26
Vancouver Luncheon and Forum, Vancouver, Canada (October 20, 2000), 2000
Box 26
"Genetic Advances and their Impact on Diagnosis and Treatment," The Business Council, Boca Raton, FL (October 27, 2000), 2000
Box 26
"Currents of Change," AAMC Council of Deans, Chicago, IL (October 30, 2000), 2000
Box 26
Duke University Health System Board of Directors Executive Committee (November 2, 2000), 2000
Box 26
New Faculty Orientation, Duke University, Durham, NC (November 6, 2000), 2000
Box 26
DUHS Leadership Networking Meeting, Durham, NC (November 7, 2000), 2000
Box 26
United Way Thank You Celebration, Duke University, Durham, NC (November 8, 2000), 2000
Box 26
Board of Visitors (November 10, 2000), 2000
Box 26
"Investing in Clinical Research," Burroughs Wellcome Lecture, University of Missouri-Kansas City, Kansas City, MO (November 14, 2000), 2000
Box 26
Board of Trustees (December 1, 2000), 2000
Box 26
Medical Center Affairs Committee (December 1, 2000), 2000
Box 26
"The Role of Academic Health Centers in Improving our Nation's Health," The 50 Group, Research Triangle Park, NC (January 11, 2001), 2000-2001
Box 26
Martin Luther King, Jr. Celebration, Duke University, Durham, NC (January 15, 2001), 2001
Box 26
Patient Resource Management Orientation, Duke University, Durham, NC (January 22, 2001), 2000-2001
Box 26
"The Role of Academic Health Centers in Our Nation's Health," The William B. Kerr Symposium (February 2, 2001), 2001
Box 26
Board of Directors (February 22, 2001), 2001
Box 26
"The Transformation of Medicine," Benenson Lunch (March 1, 2001), 2001
Box 26
"The Future of Medicine," Palm Beach Forum, Palm Beach, FL (March 2, 2001), 2001
Box 26
"Changing Role of Academic Health Centers in our Nation's Health," Faith in the Future Symposium, Duke University, Durham (March 4, 2001), 2000-2001
Box 26
"AMCs: Positioning for Success in a Rapidly Changing Health Care Environment," Leadership for Executives in the Health Professions (LEAP), Durham, NC (March 5, 2001), 2001
Box 26
"The Future of Medicine," Medical Parents' Weekend (March 17, 2001), 2001
Box 26
"The Role of Academic Health Centers in our Nation's Health," Duke Private Sector Conference (March 18, 2001), 2001
Box 26
Nearly New Shoppe / Medical Wives Luncheon, Washington Duke Inn, Durham, NC (April 12, 2001), 2001
Box 26
Hippocratic Oath Ceremony, Duke University, Durham, NC (May 11, 2001), 2001-2003
Box 26
Maimonides Ceremony, Duke University, Durham, NC (May 12, 2001), 2001
Box 26
"Highlights of the 2000-2001 Academic Year," Board of Visitors (June 1, 2001), 2001
Box 26
DUHS Board of Directors Executive Committee (August 23, 2001), 2001
Box 26
"Annual Report," DUHS Board of Directors (October 4, 2001), 2001
Box 26
New Trustee Orientation (October 4, 2001), 2001
Box 26
"Report on the Health System," Duke University Board of Trustees (October 6, 2001), 2001
Box 26
"The Importance of Genomics to Society and Duke's Role," Synergy Summit (October 26, 2001), 2001
Box 26
New Faculty Orientation (November 15, 2001), 2001
Box 26
Julian Robertson Visit Talk (December 5, 2001), 2001
Box 26
Roy Bostock and John Pepper Talk, DUHS Marketing Presentation (December 6, 2001), 2001
Box 26
"Prospective Health Planning," AAMC Officers' Retreat (December 13, 2001), 2001
Box 26
Blue Cross / Blue Shield of North Carolina Health Care & Technology Committee (January 23, 2002), 2002
Box 26
"Duke University Health System," Beverly Perdue Visit (February 18, 2002), 2002
Box 26
Ruben King-Shaw, Jr. (March 1, 2002), 2002
Box 26
"Prospective Health Care Planning: Can it Transform Health Care?" Duke Private Sector Conference (March 17, 2002), 2002
Box 26
Lauch Faircloth and Colleagues (March 26, 2002), 2002
Box 26
DUHS Board of Directors Executive Committee (April 4, 2002), 2002
Box 26
"New Directions for Universities," University of Cincinnati Spring Symposium, University of Cincinnati, Cincinnati, OH (April 30, 2002), 2001-2002
Box 26
Piedmont Orthopedic Society 50th Anniversary Meeting (May 14, 2002), 2002
Box 26
Clinical Enterprise Leadership Retreat (May 22, 2002), 2002
Box 26
Alumni Event (June 19, 2002), 2002
Box 26
Medical School Faculty Wives and the Nearly New Shoppe Appreciation Luncheon, Durham, NC (June 25, 2002), 2002
Box 26
"Prospective Health Care Planning: Can it Transform Health Care?" AAMC Task Force on Prospective Health Planning (July 22, 2002), 2002
Box 26
"The Honorable Beverly Perdue" (July 26, 2002), 2002
Box 26
Medical School Class of 2006 Orientation (August 9, 2002), 2002
Box 26
Vancouver Forum (September 21, 2002), 2002
Box 26
"Prospective Medicine: The Next Health Care Transformation," Women, Wellness and the Transformation of Health Care (October 13, 2002), 2002
Box 26
Medical Alumni Association Awards Luncheon, Washington Duke Inn, Durham, NC (October 18, 2002), 2002
Box 26
"Prospective Medicine: The Next Health Care Transformation," Presentation to Dr. Myrl Weinburg (October 22, 2002), 2002
Box 26
"Chancellor's Report," DUMC Board of Visitors (October 24, 2002), 2002
Box 26
"Prospective Medicine: The Next Health Care Transformation," Durham County Health Summit, Durham, NC (October 29, 2002), 2002
Box 26
Duke Comprehensive Cancer Center Board Meeting, Durham, NC (November 1, 2002), 2002
Box 26
"Prospective Medicine: The Next Health Care Transformation," AAMC Chair Address (November 10, 2002), 2002
Box 26
"Prospective Health Care: Fulfilling the Promise of Medicine," Bracco Diagnostics Summit (November 20, 2002), 2002
Box 26
"Prospective Health Care: Fulfilling the Promise of Medicine," Palm Beach Forum (March 13, 2003), 2003
Box 26
"Prospective Health Care: 2003," Duke Health Sector Conference (March 30, 2003), 2003
Box 26
"Prospective Health Care: 2003," Steps to a Healthier US Conference (April 16, 2003), 2003
Box 26
"Prospective Medicine: The Next Health Care Transformation," Department of Medicine Grand Rounds (May 2, 2003), 2003
Box 26
Duke University Board of Trustees Meeting (May 10, 2003), 2003
Box 26
Maimonides Ceremony, Duke University, Durham, NC (May 10, 2003), 2003
Box 26
House Staff Orientation (June 20, 2003; July 1, 2003), 2003
Box 26
Executive Management Committee (July 30, 2003), 2003
Box 27
"Genomic Medicine: From Sequence to Health," International Genome Sequencing and Analysis Conference, Savannah, GA (September 22, 2003), 2003
Box 27
New Trustee Orientation (October 2, 2003), 2003
Box 27
Board of Visitors (October 17, 2003), 2003
Box 27
"Prospective Health Care," International Life Sciences Summit, Georgetown, Washington, D.C. (October 20-21, 2003), 2003
Box 27
Durham Health Summit, Durham, NC (November 12, 2003), 2003
Box 27
"Genomic Medicine: From Sequence to Health," Intersouth Partners Annual Meeting, Chapel Hill, NC (December 10, 2003), 2003
Box 27
AAMC Task Force on Clinical Research, undated
Box 27
"Medical Education Panel: Perspective from the Academic Health Center," Health Care Reform Hearing, Testimony of Dr. Snyderman (February 1, 1994), 1993-1994
Box 27
Interview: Dr. Snyderman by "Journal of Investigative Medicine," "Making the Move into Industry" Article, June 1995
Box 27
Interview: Dr. Snyderman by "Business North Carolina," "Bitter Pill" Article, September 1996
Box 27
Interview: Dr. Snyderman by "Journal of Investigative Medicine," "The JIM Interview: Ralph Snyderman, MD.", October 1996
Box 27
Interview: Dr. Snyderman by "Journal of Investigative Medicine," "Department of Health and Human Services Moves to Rein In Medicare Audits of Teaching Hospitals" Article, August 1997
Box 27
Interview: Dr. Snyderman by "AAMC Reporter," "Research Threatened by Funding Pressures, Insurance Restrictions" Article, December 1997 - January 1998
Box 27
Interview: Dr. Snyderman by "Chronicle of Higher Education," "Duke U. and NIH Collaborate to Train Clinical Researchers" Article, November 27, 1998
Box 27
Interview: Dr. Snyderman by "Business Leader," "Other Leaders of Note: Dr. Ralph Snyderman" Article, January 1998
Box 27
Interview: Dr. Snyderman by "Chicago Tribune" (November 5, 2000), 2000
Box 27
Interview: Dr. Snyderman by Marcia Landskroener, "Good Medicine Makes Good Drama" Article, 2000
Box 27

5. Travel Files, 1983-2006

Series Scope and Contents: This series contains materials related to travel planning and trips undertaken by Snyderman for either professional or personal reasons. Travel files pertaining to professional conferences, meetings, or talks comprise the bulk of this series. Types of materials include travel itineraries, receipts and reimbursement forms, airline and car-rental tickets, and correspondence regarding travel and meeting arrangements. Also included are conference, meeting, and event materials such as memoranda, agendas, programs, correspondence, and presentation slides and notes. Some of the trips represented in this series have corresponding presentation material housed in the Presentations and Talks Series. Materials date from 1983 to 2006.

Meetings Attended, 1984-2006

Subseries Scope and Contents: Materials in this subseries pertain to meetings and events attended by Snyderman and date from 1984 to 2006.

University of Texas, Houston, TX (January 17-18, 1985), 1984-1985
Box 27
Inflammatory Process Planning Session, Scottsdale, AZ (January 27-29, 1985); Arthritis Foundation Center Grants Subcommittee, Denver, CO (January 30-31, 1985), 1984-1985
Box 27
University of Michigan - Visiting Professor, Ann Arbor, MI (February 20-22, 1985), 1984-1985
Box 27
Ad Hoc Arthritis Advisory Group, NIH, Washington, D.C. (February 24-25, 1985), 1984-1985
Box 27
Pfizer Conference, Arrowwood Conference Center, Rye Brook, NY (March 3-5, 1985), 1984-1985
Box 27
Immunology Program Review at HHMI Facilities, Coconut Grove, Miami, FL (March 31 - April 2, 1985), 1985
Box 27
Advances in Musculoskeletal and Rheumatic Diseases: Diagnosis and Management Symposium, Arlington, VA (April 17-18, 1985), 1985
Box 27
FASEB Meeting, Anaheim, CA (April 22-26, 1985), 1985
Box 27
ARA Long Range Planning Committee Meeting and AFCR Meeting, Washington, D.C. (May 3-6, 1985), 1985
Box 27
University of Pennyslvania, Philadelphia, PA (May 15, 1985), 1984-1985
Box 27
Downstate Medical Center, New York City, NY (May 17-19, 1985), 1985
Box 27
Washington, D.C. (June 10-11, 1985), 1985
Box 27
Harvard Medical School, Boston, MA (June 12, 1985), 1985
Box 27
New York University Medical Center, New York City, NY (June 13, 1985), 1985
Box 27
Gordon Research Conference on Phagocytes, Andover, NH (July 1-3, 1985), 1985
Box 27
Newport Workshop, Newport, RI (July 22-23, 1985), 1985
Box 27
National Arthritis Advisory Board Meeting, San Francisco, CA (September 4-6, 1985), 1985
Box 27
Paget's Disease of Bone Workshop, NIH, Bethesda, MD (September 12-13, 1985), 1985
Box 27
Emory University, Atlanta, GA (September 20, 1985), 1985
Box 27
Inflammatory Processes Meeting, Washington, D.C. (October 4-6, 1985), 1985
Box 27
University of Florida, Gainesville, FL (October 14-15, 1985), 1984-1985
Box 27
National Arthritis Advisory Board (NAAB) Meeting, NIH, Bethesda, MD (November 1, 1985), 1985
Box 27
National Arthritis Advisory Board (NAAB) Planning Committee for Molecular Biology & Rheumatic Diseases Conference (November 1-3, 1985), 1985
Box 27
Workshop on Retroviruses and Immunosuppression, Miami, FL (November 4, 1985), 1985
Box 27
Macy Foundation Interactive Video Project, University of Wisconsin, Madison, WI (November 11, 1985), 1985
Box 27
University of Heidelburg, Heidelburg, West Germany (November 17, 1985 - January 17, 1986), 1985-1986
Box 27
Emory University, Atlanta, GA (December 20, 1985), 1985-1986
Box 27
National Advisory Allergy and Infectious Diseases Council, Bethesda, MD (May 18-19, 1987), 1987
Box 27
Gordon Conference on Phagocytes, Andover, NH (June 29 - July 3, 1987), 1985-1987
Box 27
FASEB Summer Research Conference, Vermont Academy, Saxtons River, VT (July 26-31, 1987), 1986-1987
Box 27
11th Annual International RES Congress and 24th National Meeting of the Reticuloendothelial Society, Kauai, HI (October 17-21, 1987), 1987
Box 27
World Summit of Deans and Experts on Health and Medical Education, Buenos Aires, Argentina (August 31 - September 8, 1996), 1996
Box 27
Institute of Medicine (IOM), Irving, CA; P&G Board Meeting, Cincinnati, OH (January 10-12, 1999), 1998-1999
Box 27
Council of Deans (COD) Administrative Board Meeting, Washington, D.C. (February 10-11, 1999), 1999
Box 27
Association of American Physicians (AAP) Council Meeting, New York City, NY (February 18-19, 1999), 1999
Box 27
Vail, CO (February 27 - March 6, 1999), 1999
Box 27
P&G Board Meeting, Cincinnati, OH (March 9, 1999), 1999
Box 27
Palm Beach Forum & Development Activities, West Palm Beach, FL (March 17-20, 1999), 1999
Box 27
Zinavoy Wedding, New York City, NY; NCAA Final Four, St. Petersburg, FL (March 27-28, 1999), 1999
Box 27
AAMC Council of Deans (COD) Spring Meeting, Santa Barbara, CA (April 17-20, 1999), 1999
Box 27
Association of American Physicians (AAP) Meeting, Chicago, IL (April 24-25, 1999), 1999
Box 27
Clinical Research Task Force, Rosemont, IL (May 28, 1999), 1999
Box 27
Council of Deans (COD) Administrative Board Meeting, Washington, D.C. (June 9, 1999), 1999
Box 27
ASEE Annual Conference & Exposition, Charlotte, NC (June 21, 1999), 1999
Box 27
New York City Development Activities, New York City, NY (June 21-22, 1999), 1999
Box 27
Seattle Sabbatical (Bill and Melinda Gates Event), Seattle, WA (June 26-27, 1999), 1999
Box 27
Institute of Medicine (IOM) Council Meeting, Washington, D.C. (July 11-13, 1999), 1999
Box 27
P&G Board Meeting, Cincinnati, OH (July 13, 1999), 1999
Box 27
Integrative Medicine Consortium, Fetzer Institute, Kalamazoo, MI (July 30 - August 1, 1999), 1999
Box 27
AAMC Clinical Research Task Force Editorial Group Meeting, Washington, D.C. (August 5, 1999), 1999
Box 27
Administrative Council Retreat, Asheville, NC (August 16-17, 1999), 1999
Box 27
California Development Trip, San Francisco, CA (August 29 - September 4, 1999), 1999
Box 27
Klausner Meeting - National Cancer Institute & Clinical Research Summit Process Planning Meeting, Arlington, VA (September 10, 1999), 1999
Box 27
P&G Board Meeting, Cincinnati, OH (September 13-14, 1999), 1999
Box 27
Council of Deans (COD) Administrative Board Meeting, Washington, D.C. (September 22-23, 1999), 1999
Box 27
P&G Board Meeting, Cincinnati, OH (October 12, 1999), 1999
Box 27
New York City Development Trip, New York City, NY (October 20, 1999), 1999
Box 27
AAMC Annual Meeting, Council of Deans (COD), Washington, D.C. (October 23-25, 1999), 1999
Box 27
Vancouver Forum, Vancouver, BC, Canada (October 29-31, 1999), 1999
Box 27
Duke University Medical Center Alumni Event & the 11th Annual A. J. Kauvar, M.D. Visiting Professorship Talk, Denver, CO (November 8-10, 1999), 1999
Box 27
AAMC / Council of Deans (COD) Officers' Retreat, Queenstown, MD (December 6-8, 1999), 1999
Box 27
Institute of Medicine (IOM) Council Meeting, Washington, D.C.; P&G Board Meeting, Cincinnati, OH (January 10-11, 2000), 1999-2000
Box 27
AAMC Press Briefing on Clinical Research, AAMC Headquarters, Washington, D.C. (January 13, 2000), 2000
Box 27
Forum Club, Naples, FL (January 27-28, 2000), 1999-2000
Box 27
Association of American Physicians (AAP) Council, Washington, D.C. (February 10-12, 2000), 2000
Box 27
Council of Deans (COD) Administrative Board, Washington, D.C. (February 17-18, 2000), 1999-2000
Box 27
RealMed Corporation Board Meeting, Indianapolis, IN (February 28, 2000), 2000
Box 27
Project Medical Education, Washington, D.C. (March 1, 2000), 2000
Box 27
Palm Beach Forum, Palm Beach, FL (March 5-8, 2000), 2000
Box 27
NCAA Tournament (March 10, 2000), 2000
Box 27
P&G Board Meeting, Cincinnati, OH (March 14, 2000), 2000
Box 27
Ariad Board Meeting, Cambridge, MA (March 30, 2000), 2000
Box 27
P&G Board Meeting, Cincinnati, OH (April 11, 2000), 2000
Box 27
Miami Trip, FL - RS Personal (April 22-23, 2000), 2000
Box 27
American Society for Clinical Investigation (ASCI) / Association of American Physicians (AAP) Joint Meeting, Baltimore, MD (May 6-7, 2000), 2000
Box 27
Doris Duke Clinical Scientist Annual Meeting, Warrenton, VA (May 7, 2000), 2000
Box 27
Council of Deans (COD) Administrative Board, Washington, D.C. (June 15, 2000), 2000
Box 27
Institute of Medicine (IOM), Washington, D.C.; P&G Board Meeting, Cincinnati, OH (July 10-11, 2000), 2000
Box 27
Rosemond / Paulucci Fishing Trip, Brennan Lake, Ontario, Canada (July 31 - August 5, 2000), 2000
Box 28
Development Trip, Columbus, OH; Buckeye Lake (August 12-13, 2000), 2000
Box 28
Ted's Graduation, Smith College, Northampton, MA (August 18, 2000), 2000
Box 28
Medtronic CEO Summmit, Minneapolis, MN (August 22-23, 2000), 2000
Box 28
Boston, MA (September 8, 2000), 2000
Box 28
Fred Friendly Seminar, Washington, D.C. (September 8, 2000), 2000
Box 28
Integrative Medicine Consortium, Tucson, AZ (September 8-10, 2000), 2000
Box 28
Washington College Board of Visitors and Governors Meeting, Chestertown, MD (September 15, 2000), 2000
Box 28
Council of Deans (COD) Administrative Board Meeting, Washington, D.C. (September 21, 2000), 2000
Box 28
Institute of Medicine (IOM) Meeting, National Academy of Sciences, Washington, D.C. (October 15-18, 2000), 2000
Box 28
Vancouver Forum, Vancouver, BC, Canada (October 20-22, 2000), 2000
Box 28
AAMC Annual Meeting and Council of Deans (COD) Meeting, Chicago, IL (October 28-30, 2000) (folder 1 of 2), 2000
Box 28
AAMC Annual Meeting and Council of Deans (COD) Meeting, Chicago, IL (October 28-30, 2000) (folder 2 of 2), 2000
Box 28
Wellcome Professorship, University of Missouri-Kansas City, Kansas City, MO (November 13-15, 2000), 2000
Box 28
Ariad Board Meeting, Cambridge, MA (December 5, 2000), 2000
Box 28
AAMC Officers' Retreat, Queenstown, MD (December 6-8, 2000), 2000
Box 28
Alliance for Lupus Research Scientific Advisory Board, New York City, NY (December 8-10, 2000), 2000-2001
Box 28
P&G Board Meeting, Cincinnati, OH (December 12, 2000), 2000
Box 28
Society of Medical Administrators (SOMA) Meeting, Carlsbad, CA (January 5-8, 2001), 2000-2001
Box 28
FFT CEO Summit, Vail, CO (January 30 - February 1, 2001), 2000-2001
Box 28
William B. Kerr Symposium, UCSF Campus, San Francisco, CA (February 1-3, 2001), 2000-2001
Box 28
AAMC Executive Council and Administrative Boards Meeting, Washington, D.C. (February 8-9, 2001), 2001
Box 28
Washington College Board of Visitors and Governors Meeting, Chestertown, MD (February 16-17, 2001), 2001
Box 28
Palm Beach Forum, Palm Beach, FL (February 28 - March 2, 2001), 2000-2001
Box 28
ACC Tournament, Atlanta, GA (March 11, 2001), 2001
Box 28
Dinner with Dr. Francis Collins, Washington, D.C. (March 12, 2001), 2001
Box 28
P&G Board Meeting, Cincinnati, OH (March 13, 2001), 2001
Box 28
Final Four Weekend, Minneapolis, MN (March 31 - April 2, 2001), 2001
Box 28
Integrative Medicine Forum, Tucson, AZ (April 4-7, 2001), 2000-2001
Box 28
P&G Board Meeting, Cincinnati, OH (April 9-10, 2001), 2000-2001
Box 28
Council of Deans (COD) Spring Meeting, Tucson, AZ (April 21-24, 2001), 2001
Box 28
American Society for Clinical Investigation (ASCI) / Association of American Physicians (AAP) Joint Meeting, Chicago, IL (April 27-29, 2001), 2000-2001
Box 28
New York City, NY (June 4, 2001), 2001
Box 28
P&G Board Meeting, Cincinnati, OH (June 12, 2001), 2001
Box 28
AAMC Executive Council, Washington, D.C. (June 26-28, 2001) (folder 1 of 2), 2001
Box 28
AAMC Executive Council, Washington, D.C. (June 26-28, 2001) (folder 2 of 2), 2001
Box 28
Rosemond Fishing Trip, Brennan Lake, Ontario, Canada (July 30 - August 4, 2001), 2001
Box 28
P&G Board Meeting, Cincinnati, OH (September 10-11, 2001), 2001
Box 28
Washington College Board of Visitors and Governors Meeting, Chestertown, MD (September 14-15, 2001), 2001
Box 28
Chancellor's Circle at Pinehurst, NC (September 15-16, 2001), 2001
Box 28
P&G Board Meeting, Cincinnati, OH (October 9, 2001), 2001
Box 28
Development Trip, New York City, NY (October 10, 2001), 2001
Box 28
"Models of Integrative Care: Present and Future" Conference, San Francisco, CA (October 27-28, 2001), 2001
Box 28
Washington College Board of Visitors and Governors Retreat, St. Michael's, MD (November 2-3, 2001), 2001
Box 28
AAMC Annual Meeting, Washington, D.C. (November 3-6, 2001) (folder 1 of 2), 2001
Box 28
AAMC Annual Meeting, Washington, D.C. (November 3-6, 2001) (folder 2 of 2), 2001
Box 28
Alliance for Lupus Research Scientific Advisory Board, New York City, NY (November 30 - December 2, 2001), 2001
Box 28
P&G Board Meeting, Cincinnati, OH (December 11, 2001), 2001
Box 28
AAMC Officers' Retreat, Queenstown, MD (December 12-14, 2001) (folder 1 of 2), 2001
Box 28
AAMC Officers' Retreat, Queenstown, MD (December 12-14, 2001) (folder 2 of 2), 2001
Box 28
Meeting with Governor Tom Ridge, The White House, Washington, D.C. (December 17, 2001), 2001
Box 28
Development Trip, New York City, NY (December 18, 2001), 2001
Box 28
West Palm Beach, FL (December 27, 2001), 2001
Box 28
New York City, NY (January 5-6, 2002), 2001-2002
Box 28
P&G Board Meeting, Cincinnati, OH (January 8, 2002), 2001-2002
Box 28
Workshop on the Roles of Academic Health Centers in the 21st Century, Washington, D.C. (January 24-25, 2002), 2001-2002
Box 29
Alfalfa Club Dinner, Washington, D.C. (January 26, 2002), 2001-2002
Box 29
FFT CEO Summit, Vail, CO (January 28 - February 1, 2002), 2001-2002
Box 29
Charlotte, NC (February 4, 2002), 2001-2002
Box 29
Association of American Physicians (AAP) Meeting, San Francisco, CA (February 14-15, 2002), 2000-2002
Box 29
AAMC Executive Committee Meeting, Washington, D.C. (February 27-28, 2002) (folder 1 of 2), 2002
Box 29
AAMC Executive Committee Meeting, Washington, D.C. (February 27-28, 2002) (folder 2 of 2), 2002
Box 29
Palm Beach, FL (March 5-7, 2002), 2001-2002
Box 29
Council of Teaching Hospitals (COTH) Spring Meeting, New Orleans, LA (March 6-8, 2002), 2001-2002
Box 29
P&G Board Meeting, Cincinnati, OH (March 12, 2002), 2002
Box 29
P&G Off-Site Board Visit, Geneva, Switzerland (April 4-9, 2002), 2002
Box 29
AAMC Council of Deans (COD) Spring Meeting, Savannah, GA (April 20-23, 2002), 2001-2002
Box 29
American Society for Clinical Investigation (ASCI) / Association of American Physicians (AAP) Meeting, Chicago, IL (April 26-28, 2002), 2001-2002
Box 29
Spring Symposium, University of Cincinnati, Cincinnati, OH (April 30, 2002), 2001-2002
Box 29
AAMC Executive Council, Washington, D.C. (June 18-20, 2002), 2002
Box 29
Medical Alumni Event, Washington, D.C. (June 19, 2002), 2002
Box 29
P&G Board Meeting, Cincinnati, OH (July 9, 2002), 2002
Box 29
SAIC Board Meeting, San Diego, CA (July 11-12, 2002), 2002
Box 29
AAMC Prospective Health Care Meeting, Washington, D.C. (July 22, 2002), 2002
Box 29
Alliance for Lupus Research (ALR) / FDA SLE Working Group Meeting, Washington, D.C. (July 23, 2002), 2002
Box 29
Dinner, Linville Ridge, NC (August 2, 2002), 2002
Box 29
Alliance for Lupus Research Scientific Advisory Board / Cardiome Board of Directors, Atlanta, GA (August 5-6, 2002), 2002
Box 29
Rosemond Fishing Trip, Brennan Lake, Ontario, Canada (August 12-17, 2002), 2002
Box 29
P&G Board Meeting, Cincinnati, OH (September 10, 2002), 2002
Box 29
AAMC Executive Committee Meeting, Washington, D.C. (September 18-19, 2002), 2002
Box 29
Vancouver Forum, Vancouver, BC, Canada (September 20-22, 2002), 2002
Box 29
P&G Board Meeting, Cincinnati, OH (October 8, 2002), 2002
Box 29
SAIC Board Meeting, East Brunswick, NJ (October 11, 2002) - Via Conference Call, 2002
Box 29
AAMC Annual Meeting, San Francisco, CA (November 9-12, 2002) (folder 1 of 2), 2002
Box 29
AAMC Annual Meeting, San Francisco, CA (November 9-12, 2002) (folder 2 of 2), 2002
Box 29
Bracco Diagnostics, Inc. Executive Summit, New York City, NY (November 19-20, 2002), 2002-2003
Box 29
P&G Board Meeting, Cincinnati, OH (December 10, 2002), 2002
Box 29
AAMC Compensation Committee (December 11, 2002), 2002
Box 29
AAMC Senior Officers Retreat, Queenstown, MD (December 11-13, 2002), 2002
Box 29
Alliance for Lupus Research (ALR) Scientific Advisory Board, New York City, NY (December 16-17, 2002), 2002-2003
Box 29
SAIC Board Meeting, La Jolla, CA (January 9-10, 2003), 2002-2003
Box 29
P&G Board Meeting, Cincinnati, OH (January 14, 2003), 2002-2003
Box 29
FFT CEO Summit, Aspen, CO (January 27-30, 2003), 2002-2003
Box 29
Association of American Physicians (AAP) Council, Chicago, IL (February 12-13, 2003), 2003
Box 29
P&G Board Meeting, Cincinnati, OH (March 11, 2003), 2003
Box 29
Palm Beach Forum, Palm Beach, FL (March 11-13, 2003), 2003
Box 29
Foundation Visits, Philadelphia, PA (March 20, 2003), 2003
Box 29
SAIC Board Meeting, McLean, VA (April 10-11, 2003), 2003
Box 29
"Steps to a Healthier US" Summit, Baltimore, MD (April 16, 2003), 2003
Box 29
Development Trip, New York City, NY and Princeton, NJ (April 22, 2003), 2003
Box 29
American Society for Clinical Investigation (ASCI) / Association of American Physicians (AAP) Joint Meeting, Chicago, IL (April 25-27, 2003), 2003
Box 29
University of Rochester School of Medicine and Dentistry Commencement, Rochester, NY (May 16, 2003), 2003
Box 29
Ellis Island Medal of Honor, New York City, NY (May 17, 2003), 2003
Box 30
P&G Board Meeting, Cincinnati, OH (June 9-10, 2003), 2003
Box 30
Graduate Medical School Memorandum of Understanding (MOU) Signing Ceremony, Singapore (June 24-28, 2003), 2003
Box 30
SAIC Board Meeting, La Jolla, CA (July 10-11, 2003), 2003
Box 30
Lexicon Genetics, Inc., The Woodlands, TX (August 6, 2003), 2003
Box 30
Cardiome Board Meeting, Vancouver, BC, Canada and San Francisco, CA (August 14-22, 2003), 2003
Box 30
P&G Board Meeting, Cincinnati, OH (September 9, 2003), 2003
Box 30
Institute of Medicine - "Challenges Facing the Clinical Research Enterprise," Washington, D.C. (September 10, 2003), 2003
Box 30
15th International Genome Sequencing and Analysis Conference, Savannah, GA (September 22, 2003) (folder 1 of 2), 2003
Box 30
15th International Genome Sequencing and Analysis Conference, Savannah, GA (September 22, 2003) (folder 2 of 2), 2003
Box 30
15th International Genome Sequencing and Analysis Conference, Savannah, GA (September 22, 2003) [oversized], 2003
Box 39
SAIC Board Meeting, East Brunswick, NJ (October 9-10, 2003), 2003
Box 30
The Biotech Meeting at Laguna Niguel, Dana Point, CA (October 9-13, 2003), 2003
Box 30
The International Life Sciences Summit, Georgetown University, Washington, D.C. (October 20-21, 2003), 2003
Box 30
AAMC Annual Meeting, Washington, D.C. (November 8-10, 2003), 2003
Box 30
Bravewell Leadership Award, The Regent Wall Street, New York City, NY (November 13, 2003), 2003
Box 30
Cardiome Board Meeting, Miami, FL (November 16-18, 2003), 2003-2004
Box 30
Robert Wood Johnson Medical School Board of Overseers, New Brunswick, NJ (December 1, 2003), 2003
Box 30
New York City, NY (December 11-13, 2003), 2003-2004
Box 30
P&G Board Meeting, Cincinnati, OH (December 8-9, 2003), 2003
Box 30
Travel Itineraries, 2004
Box 30
SAIC Board Meeting, San Diego, CA (January 8-9, 2004), 2003-2004
Box 30
Society of Medical Administrators (SOMA), Boulders Resort and Golden Door Spa, Carefree, AZ (January 10-13, 2004), 2003-2004
Box 30
P&G Board Meeting, Cincinnati, OH (January 12-13, 2004), 2003-2004
Box 30
Keystone Symposium: Genomic Biomarkers Impact on Drug Discovery and Clinical Practice, Sante Fe, NM (January 26, 2004), 2003-2004
Box 30
Scientific Advisory Committee Meeting - 28th Annual MGH Research Symposium: A Celebration of Science & 57th Annual MGH Scientific Advisory Committee Meeting, Massachusetts General Hospital, Boston, MA (February 4-6, 2004), 2003-2004
Box 30
National Center for Complementary and Alternative Medicine Strategic Plan Advisory Panel, NIH, Washington, D.C. (February 13, 2004), 2003-2004
Box 30
Washington College Board of Visitors and Governors, Chestertown, MD (February 20-21, 2004), 2004
Box 30
P&G Board Meeting, Cincinnati, OH (March 9, 2004), 2004
Box 30
Palm Beach Forum, Palm Beach, FL (March 15-18, 2004), 2004
Box 30
Axonyx Board Meeting, New York City, NY (March 30, 2004), 2004
Box 30
Final Four, San Antonio, TX (April 3-4, 2004), 2004
Box 30
American Society for Clinical Investigation (ASCI) / Association of American Physicians (AAP) Meeting, Chicago, IL (April 16-18, 2004), 2004
Box 30
San Francisco, CA (April 22-27, 2004), 2004
Box 30
FDA Advisory Committee, Washington, D.C. (June 2, 2004), 2004
Box 30
P&G Board Meeting, Cincinnati, OH (June 8, 2004), 2004
Box 30
Nelson Shanks Studio Portrait Sitting, Philadelphia, PA (June 10-12, 2004), 2004
Box 30
Life Sciences Leader Recruitment Consultation, University of Missouri, Kansas City, MO (June 15, 2004), 2004
Box 30
Axonyx Board Meeting, New York City, NY (June 22, 2004), 2004
Box 30
Nelson Shanks Studio Portrait Sitting, Philadelphia, PA (July 8, 2004), 2004
Box 30
P&G Board Meeting, Cincinnati, OH (July 12-13, 2004), 2004
Box 30
SAIC Board Meeting, San Diego, CA (July 15-16, 2004), 2004
Box 30
Nelson Shanks Studio Portrait Sitting, Philadelphia, PA (July 27, 2004), 2004
Box 30
Raleigh-Durham (RDU) to San Francisco, CA (August 3, 2004), 2004
Box 30
San Francisco Trip - Cindy Mitchell and Abby Conaway (August 12-14, 2004), 2004
Box 30
Cardiome Board Meeting, Sonora Island, Canada (August 15-20, 2004), 2004
Box 30
P&G Board Meeting, Cincinnati, OH (September 13-14, 2004), 2004
Box 30
Washington College Board of Visitors Retreat, Wye Woods Conference Center, Queenstown, MD (September 30 - October 2, 2004), 2004
Box 30
Association of Academic Health Centers (AAHC) Annual Meeting, Tucson, AZ (October 6-9, 2004), 2004
Box 30
Symposium of Integrative Medicine Professionals in the Land of Enchantment, Albuquerque, NM (October 14-17, 2004), 2003-2004
Box 30
Cardiome Board Meeting, Miami, FL (November 7-8, 2004), 2004
Box 30
Bravewell Collaborative Meeting: The Philanthropic Collaborative for Integrative Medicine, Washington Duke Inn, Durham, NC (November 10, 2004), 2003-2004
Box 30
SingHealth Leadership Series, Singapore (November 14-21, 2004), 2004
Box 31
University of California, Riverside, CA (November 23, 2004), 2004-2005
Box 31
P&G Board Meeting, Cincinnati, OH (December 13-14, 2004), 2004
Box 31
Integrative Medicine Retreat, El Capitan Canyon, Santa Barbara, CA (December 17-19, 2004), 2004-2005
Box 31
San Francisco to Raleigh Durham (RDU) Flight (December 21-29, 2004), 2004
Box 31
P&G Board Meeting, Cincinnati, OH (January 11, 2005), 2004-2005
Box 31
Axonyx Board Meeting, New York City, NY (January 23-24, 2005), 2004-2005
Box 31
SAIC Board Meeting, Walt Disney World's Boardwalk, Orlando, FL (January 13-14, 2005), 2004-2005
Box 31
FFC CEO Summit, Aspen, CO (January 31 - February 3, 2005), 2004-2005
Box 31
Massachusetts General Hospital Scientific Advisory Board, Boston, MA (February 16-18, 2005), 2004-2005
Box 31
Association of American Physicians (AAP) Meeting, Philadelphia, PA (February 18, 2005), 2004-2005
Box 31
P&G Board Meeting, Cincinnati, OH (March 8, 2005), 2005
Box 31
GE Healthcare Scientific Advisory Meeting, New York City, NY (March 13-15, 2005), 2005
Box 31
Axonyx Board Meeting, New York City, NY (March 29, 2005), 2005
Box 31
Albert Eye Institute Dedication, Durham, NC (April 8, 2005), 2004-2005
Box 31
P&G Board Meeting/Retreat, Palm Beach, FL (April 9-11, 2005), 2005
Box 31
American Society for Clinical Investigation (ASCI) / Association of American Physicians (AAP) Joint Meeting, Chicago, IL (April 15-17, 2005), 2005
Box 31
NEA Partners Meeting, Baltimore, MD (April 18, 2005), 2005
Box 31
Washington College Board of Visitors and Governors Meeting, Chestertown, MD (April 22, 2005), 2005
Box 31
NCCAM Distinguished Lecture, NIH, Washington, D.C. (April 21-22, 2005), 2005
Box 31
P&G R&D University for Band V Directors, Cincinnati, OH (May 11-12, 2005), 2005
Box 31
Culinary Institute, Napa Valley, CA (May 23-26, 2005), 2004-2005
Box 31
Cardiome Board Meeting, Vancouver, BC, Canada (June 6, 2005), 2005
Box 31
Pacific Health Summit, Seattle, WA (June 8-10, 2005), 2005
Box 31
P&G Board Meeting, Cincinnati, OH (June 13-14, 2005), 2005
Box 31
Axonyx Annual Meeting and Board Meeting, New York City, NY (June 16, 2005), 2005
Box 31
Raleigh Durham (RDU) to San Francisco Flight (June 21, 2005), 2005
Box 31
XDx Board of Directors Meeting, San Francisco, CA (June 30, 2005), 2005
Box 31
LifeMasters Board Meeting, San Francisco, CA (July 23-28, 2005), 2005
Box 31
P&G Board Meeting, Cincinnati, OH (August 9, 2005), 2005
Box 31
MiddleMarch Films PBS "Good Medicine" Documentary, New York City, NY (August 17, 2005), 2005
Box 31
Rosemond Fishing Trip, Ontario, Canada (August 28 - September 2, 2005), 2005
Box 31
Burrill Japan Biotech Meeting, Japan; San Francisco Visit, San Francisco, CA (September 2-11, 2005), 2005
Box 31
XDx Board Meeting, San Francisco, CA (September 7, 2005), 2005
Box 31
IBM Lab Briefing, Hawthorne, NY (September 13, 2005), 2005
Box 31
Washington College Board of Visitors, Chestertown, MD (September 16-17, 2005), 2005
Box 31
Bravewell Leadership Award Selection Committee, New York City, NY (October 5-6, 2005), 2005
Box 31
3rd Annual Burrill Portfolio CEO Meeting, Laguna Niguel, CA (October 8-11, 2005), 2005
Box 31
IBM Healthcare and Life Sciences Salon Luncheon, The Harvard Club of New York, New York City, NY (October 17, 2005), 2005
Box 31
Health Policy Talk, College of William and Mary, Williamsburg, VA (October 19, 2005), 2005
Box 31
XDx Board Meeting and LifeMasters Board Meeting, San Francisco, CA (October 25 - November 2, 2005), 2005
Box 31
"Personalized Medicine" Conference, Harvard Medical School, Boston, MA (November 3, 2005), 2005-2006
Box 31
Mind and Life XII Meeting, Washington, D.C. (November 6-10, 2005), 2004-2005
Box 31
Bravewell Leadership Symposium/Dinner, New York City, NY; New York University (NYU) Medical Center, New York City, NY (November 10-11, 2005), 2005
Box 31
Lenny Lecture, Dana-Farber Cancer Institute, Boston, MA (November 17-18, 2005), 2005
Box 31
GE Healthcare Scientific Advisory Board, Chicago, IL (November 20-21, 2005), 2005
Box 31
Washington College Board of Visitors, Chestertown, MD (December 3, 2005), 2005
Box 31
Cardiome Board Meeting, East Coast (December 12, 2005), 2005-2006
Box 31
XDx Board Meeting, San Francisco, CA (December 14, 2005), 2005-2006
Box 31
Emory Symposium, Atlanta, GA (December 19-20, 2005), 2005-2006
Box 31
CEO Summit, Aspen, CO; XDx Board Meeting, San Francisco, CA; LifeMasters Board Meeting, San Francisco, CA (January 24 - February 7, 2006), 2006
Box 31
Yale Corporation Ad Hoc Committee, Hartford, CT (February 10, 2006), 2006
Box 31
Scientific Advisory Committee, Boston, MA (February 15-16, 2006), 2006
Box 31
San Francisco, CA (February 20 - March 2, 2006), 2006
Box 31
"New Medicine" - PBS Viewing, New York City, NY (March 21, 2006), 2006
Box 31
P&G Off-Site Directors Meeting, Istanbul, Turkey (April 27 - May 1, 2006), 2005-2006
Box 31
Albuquerque Academy, Albuquerque, NM (May 8, 2006), 2006
Box 31
LifeMasters Board Meeting, San Francisco, CA (May 10, 2006), 2006
Box 31
University of Tennessee Commencement, Memphis, TN (May 25-26, 2006), 2006
Box 31
New Enterprises Associates (NEA) Med Team Retreat, St. Michaels, MD (June 1-2, 2006), 2006
Box 31
Cardiome, P&G, and XDx Board Meetings, San Francisco, CA (June 10-20, 2006), 2006
Box 31
Cardiome Board of Directors Meeting, Vancouver, BC, Canada (June 11-12, 2006), 2006
Box 31
Sonora Resort/Cardiome Board of Directors Meeting, Vancouver, BC, Canada (September 13-18, 2006), 2006
Box 31

Meetings Not Attended, 1998-2006

Subseries Scope and Contents: Materials in this subseries relate to meetings and events that either were cancelled or Snyderman was unable to attend. These materials date from 1998 to 2006.

Association of Academic Health Centers (AHC) Meeting, Tucson, AZ (September 23-26, 1998), 1998
Box 31
Institute of Medicine (IOM) Meeting, Washington, D.C. (October 13-14, 1998), 1998
Box 31
Society of Medical Administrators (SOMA) Meeting, Naples, FL (January 9-12, 1999), 1998-1999
Box 31
Association of Academic Health Centers (AHC) Spring Meeting, Washington, D.C. (March 29-30, 1999), 1999
Box 31
Institute of Medicine (IOM) Council, Washington, D.C. (April 19, 1999), 1999
Box 31
Ariad Board Meeting, Boston, MA (June 25, 1999), 1999
Box 31
Dave Thomas Trip, Columbus, OH (August 14-15, 1999), 1999
Box 31
Association of Academic Health Centers (AAHC) Annual Meeting, Hilton Head, SC (September 29 - October 2, 1999), 1999
Box 31
Institute of Medicine (IOM) Meeting, Washington, D.C. (October 12-13, 1999), 1999
Box 31
AAMC Academically Oriented Health Systems Leadership Forum, Eastern Shore, MD, 1999
Box 31
Society of Medical Administrators (SOMA) Meeting, Naples, FL (January 8-11, 2000), 1999-2000
Box 31
P&G Board Meeting, Beijing, China (April 8-11, 2000), 2000
Box 31
Higher Education in Developing World and Connections Between African and American Universities - Conversation with Dr. Ramphele and Senior Administrators and Faculty, Duke University, Durham, NC (January 15, 2001), 2000-2001
Box 31
AAMC Executive Council Meeting, Washington, D.C. (September 19, 2001) - Cancelled, 2001
Box 31
DUMC Alumni Dinner, Washington, D.C. (September 25, 2001) - Cancelled, 2001
Box 31
Society of Medical Administrators (SOMA) Meeting, Boca Raton Resort, Boca Raton, FL (January 18-21, 2003), 2002-2003
Box 31
AAMC Executive Committee, Washington, D.C. (February 19-20, 2003), 2003
Box 31
Clinical Research Report Card Meeting, Cambridge, MA (March, 13-14, 2006), 2006
Box 31

Other, 1983-1989

Subseries Scope and Contents: Contains materials related to travel in general rather than specific trips. Materials include airline frequent flyer account statements, frequent flyer membership cards, correspondence regarding airline accounts, and saved travel receipts. Materials date from 1983 to 1989.

Airline Account Statements, 1987-1989
Box 31
Frequent Flyer Membership Cards, 1983-1987
Box 31
Travel Account Correspondence, 1988
Box 31
Travel Receipts, 1987-1988
Box 31

6. Genentech, 1985-1989

Series Scope and Contents: Contains research and development plans, reports, and presentations; professional correspondence to and from Snyderman; internal communications (i.e., memos and memoranda); subject files; administrative files including budgets; and materials from conferences, meetings, and other professional activities attended by Snyderman in his role as Vice President for Medical Research and Development at Genentech. These materials date from 1985 to 1989 and span Snyderman's years (1987-1989) at Genentech, Inc., a biomedical technology firm based in San Francisco, California.

Applicants, A-R, 1986-1987
Box 32
Applicants, S-Z, 1986
Box 32
Applicants: Pharmacology Director, 1986
Box 32
Applicants: Postdoctoral Scientist Position, 1986
Box 32
Blank Administrative Forms, undated
Box 32
Board Presentations, 1987-1988
Box 32
Budget, 1986
Box 32
Budget Proposals, 1987
Box 32
Consultants, 1985-1986
Box 32
Correspondence: John Gueriguian's Book, 1987-1988
Box 32
Correspondence: Letters of Recommendation, A-G, 1987-1988
Box 32
Correspondence: Letters of Recommendation, H-M, 1987-1989
Box 32
Correspondence: Letters of Recommendation, P-Z, 1987-1988
Box 32
Correspondence: Professional, 1986
Box 32
Correspondence: Professional, 1987
Box 32
Correspondence: Professional, January - April 1988
Box 32
Correspondence: Professional, May - August 1988
Box 32
Correspondence: Professional, September - December 1988
Box 32
Correspondence: Professional, 1989
Box 32
Department of Pharmacological Sciences Head Count Budget, 1986
Box 32
Duke at Vail: Frontiers in Dermatology and Rheumatology Conference, Vail, CO (February 20-27, 1988) (folder 1 of 2), 1986-1988
Box 32
Duke at Vail: Frontiers in Dermatology and Rheumatology Conference, Vail, CO (February 20-27, 1988) (folder 2 of 2), 1986-1988
Box 32
Duke at Vail: Third Annual Symposium on Dermatologic and Rheumatic Diseases, Vail, CO (February 18-25, 1989) (folder 1 of 2), 1988-1989
Box 32
Duke at Vail: Third Annual Symposium on Dermatologic and Rheumatic Diseases, Vail, CO (February 18-25, 1989) (folder 2 of 2), 1988-1989
Box 32
Employee Performance Expectations and Goals, 1989
Box 32
Genentech, Inc. Letterheads, undated
Box 32
Genentech Publication List, August 5, 1987
Box 32
"Growth Factor Mediated Organ Repair" Presentation, undated
Box 32
Management Committee, 1987-1988
Box 32
Meetings, 1987
Box 32
Meetings [oversized], circa 1987
Box 39
Operations Committee, 1987-1989
Box 32
Project Plan Review Meeting, December 1987
Box 33
Research & Development (folder 1 of 2), 1988
Box 33
Research & Development (folder 2 of 2), 1988
Box 33
Research & Development Plans (folder 1 of 2), 1988
Box 33
Research & Development Plans (folder 2 of 2), 1988
Box 33
Research & Development Presentation Materials, 1988-1989
Box 33
Research & Development Presentation Materials [oversized], 1988
Box 39
Reports: Activase Strategic Plan (draft), 1988
Box 33
Reports: Advisory Committee Summary: Activase (Tissue Plasminogen Activator, Recombinant) (folder 1 of 2), April 1987
Box 33
Reports: Advisory Committee Summary: Activase (Tissue Plasminogen Activator, Recombinant) (folder 2 of 2), April 1987
Box 33
Reports: Alpha Company Evaluation, Sigma Company Evaluation, 1988
Box 33
Reports: Building 5 Renovation, South San Francisco, CA, Feasibility Study, 1987
Box 33
Reports: Capital Expenditure Review, October - December 1987
Box 33
Reports: Capital Expenditure Review, January - September 1988
Box 33
Reports: Extramural Research Program Report, October 30, 1987
Box 33
Reports: Monthly Financial Review, December 1986 - January 1989
Box 33
Reports: Monthly Operations Review, December 1986
Box 34
Reports: Monthly Operations Review, January - December 1987
Box 34
Reports: Monthly Operations Review, January - June 1988
Box 34
Reports: Protropin Periodic Adverse Drug Reactions, 1987
Box 34
Reports: Project Progress Summary, January - June, January - June 1988
Box 34
Strategic Planning, 1988
Box 34
Subject Files: AIDS, 1986
Box 34
Subject Files: BARK Project, 1988
Box 34
Subject Files: "Biotechnology Therapeutics", 1988
Box 34
Subject Files: Boehringer-Ingelheim, 1987
Box 34
Subject Files: CKS-17 Patent, 1987
Box 34
Subject Files: Corvas, 1989
Box 34
Subject Files: DNA Expression System, undated
Box 34
Subject Files: Duke / Genentech Relocation, 1986-1987
Box 34
Subject Files: FDA Regulations (folder 1 of 2), 1987-1988
Box 34
Subject Files: FDA Regulations (folder 2 of 2), 1987-1988
Box 34
Subject Files: Funding Requests, 1986
Box 34
Subject Files: HGH, 1986
Box 34
Subject Files: IFN, 1986
Box 34
Subject Files: Relaxin, 1988
Box 34
Subject Files: Somatogen, 1987-1988
Box 34
Subject Files: TGF-[beta], 1988
Box 34
Subject Files: tPA (Activase), 1986
Box 34
Subject Files: Triangle Licensing Consortium: "A Biologically Stable Low Molecular Weight Mimic of Superoxide Dismutase" Technology, 1988
Box 34
Travel and Expenses, 1986
Box 34
Travel and Expenses, 1987
Box 34
Travel and Expenses, 1988
Box 34

7. Personal / Biographical, 1971-1989

Series Scope and Contents: Contains biographical materials as well as some materials that relate to Snyderman's personal life. Types of materials include awards and honors, personal correspondence, correspondence concerning professional appointments, memorabilia, biographical clippings, photographs, and miscellaneous personal materials. Items in this series date from 1971 to 1989.

Award Plaque - Journal of Leukocyte Biology, March 1988
Box 34
Awards and Accolades, 1971-1988
Box 34
Correspondence: Professional Appointments, 1986-1987
Box 34
Medical - Personal and Family, 1987-1989
Box 34
Miscellaneous, undated
Box 34
Personal Correspondence and Memorabilia, 1987-1988
Box 34
Personal Correspondence and Memorabilia, 1989
Box 34
Personal Correspondence and Memorabilia, undated
Box 34
Photographs, 1983, undated
Box 34

8. Subject Files, 1969-2000

Series Scope and Contents: This series contains materials grouped together in folders based on subject prior to their receipt by the Archives. Materials are arranged alphabetically and date from 1969 to 2000.

Bionet, 1985-1986
Box 34
Boehringer-Ingelheim Ltd., 1986-1987
Box 34
Clinical Rheumatology Cases, 1983-1984
Box 34
Collagen, 1972
Box 34
Congressional Hearing, 1985-1986
Box 34
Cordis Corporation Human Complement Components, 1969
Box 34
Digital Research Computer Disks (8 inch floppy disks), 1979-1980
Box 34
"Inflammation," 3rd Edition Review in JAMA, January 5, 2000
Box 34
"Integrative Medicine" Journal, 1997-2000
Box 34
International Registry of Tumor Immunotherapy, 1977
Box 34
"Patient and Family Handbook," Immune Deficiency Foundation, 1987
Box 34
Pharmaceutical Manufacturers Association Directory of Physicians in Member Companies, 1988
Box 35
Rioprobe Gene Analysis System, undated
Box 35
Shell Oil Company Delphi Study, 1982-1983
Box 35
Syllabus: Clinical Slide Collection on the Rheumatic Diseases, 1972
Box 35
Syllabus: Revised Clinical Slide Collection on the Rheumatic Diseases, 1981
Box 35
Telios Pharmaceuticals, Inc., undated
Box 35
User Manual: dBASE II: Assembly Language Relational Database Management System, 1982
Box 35
Duke University Patent Staff, 1987-1988
Box 20

9. Slides, 1977-1985

Series Scope and Contents: Contains published resource slides and their associated presentation materials and lecture guides. Materials are dated from circa 1977 to 1985.

Notes, undated
Box 35
Resource Materials in Rheumatology (2 copies), circa 1977-1983
Box 35
Resource Materials in Rheumatology Volume II, undated
Box 35
Resource Materials in Rheumatology Volume III, 1985
Box 35
Recent Developments in the Management of Acute Myocardial Infarction Slide Lecture Guide, undated
Box 35
Thrombolytic Therapy in Acute Myocardial Infarction Draft Slide Lecture Guide, circa 1987
Box 35

Biographical Note

Ralph Snyderman, Chancellor Emeritus of Duke University, James B. Duke Professor of Medicine, and Director of the Duke Center for Research on Personalized Health Care, was born in 1940 in Brooklyn, New York to Russian immigrants Morris and Ida Snyderman. Snyderman graduated in 1961 from Washington College in Chestertown, Maryland and received his M.D., magna cum laude, from the Downstate Medical Center of the State University of New York in 1965. Following graduation, Snyderman came to Duke to conduct his internship and residency in medicine and later worked as a Public Health Officer doing research in immunology at the National Institute of Health (NIH) from 1967 to 1972.

In 1972, Snyderman accepted his first faculty appointment at Duke as a Howard Hughes Medical Investigator, Assistant Professor of Medicine and Immunology. At this time, he also served as Chief of Rheumatology at the Durham Veteran's Administration Hospital. Snyderman rose through Duke's academic ranks, becoming Chief of the Division of Rheumatology and Immunology in 1974 and Frederick M. Hanes Professor of Medicine and Immunology in 1984.

Snyderman left Duke in 1987 to join Genentech, Inc., a biomedical technology firm in San Francisco, California. There, he held the position of Vice President for Medical Research and Development and served as a member of Genentech's senior leadership team. Snyderman was promoted to Senior Vice President a year later (1988). While at Genentech, Snyderman led the development and licensing of several therapeutics and supervised roughly 300 staff members working in pharmacology, clinical research, and regulatory affairs.

Snyderman returned to Duke in 1989 when he accepted the position of Chancellor for Health Affairs and Dean of the School of Medicine, a position which he held from 1989 to 2004. In this role, Snyderman oversaw the development of the Duke University Health System (DUHS), one of the nation's successful integrated health systems, and served as DUHS first President and Chief Executive Officer. Under Snyderman's leadership, Duke's medical center grew from a single campus health care entity to an integrated health system, and the medical school and hospital ranked among the top in the nation. As Chancellor for Health Affairs and CEO of DUHS, Snyderman contributed to debates on health care reform issues before Congress, the Institute of Medicine (IOM), the NIH, and national policy makers. After retiring from the position of Chancellor for Health Affairs and Dean of the School of Medicine in 2004, Snyderman resumed teaching and researching at Duke as James B. Duke Professor of Medicine (1989-2017). His laboratory focused on defining the mechanisms which regulate chemoattractant receptors activation, desensitization, and priming. Snyderman also led the creation of the Duke Center for Research on Personalized Health Care, serving as its director.

Snyderman is internationally known for his contributions in inflammation research. As an immunologist, Snyderman's research into the mechanisms of inflammation led to worldwide recognition, including the two top scientific awards in this field (the CIBA GEIGY Award, and the Bonazinga Award for Excellence in Leukocyte Biology Research) and a lifetime achievement award from the Arthritis Foundation. His research in immunology has contributed to the understanding of the precise mechanism of how white blood cells respond to chemical signals to mediate host defense or tissue damage. For over 25 years, Snyderman has served as Principle Investigator on Investigator-initiated NIH grants and has published over 350 manuscripts as well as contributed to numerous books, such as "Inflammation: Basic Principles and Clinical Correlates" and multiple editions of "Cecil's Textbook of Medicine." Snyderman's research efforts resulted in new approaches for treating those suffering from inflammation-related diseases. He has researched and spoken extensively on arthritis treatment and periodontal health. Snyderman's areas of subject expertise include immunology, inflammation, rheumatology, and medical administration.

Snyderman has held leadership roles in several important national organizations. Among other appointments, he served as Chair of the Association of American Medical Colleges (AAMC) in 2001-2002, President of the Association of American Physicians (AAP) in 2003-2004, and chaired the Institute of Medicine's (IOM) National Summit on Integrative Medicine and the Health of the Public in February 2009. Snyderman also received membership in the American Academy of Arts and Sciences and the Institute of Medicine (IOM).

Snyderman has been the recipient of numerous awards and honors from the scientific and medical communities. He received the two most prestigious awards worldwide in the field of inflammation research: the CIBA GEIGY Award (1992) for lifetime achievement in the field of inflammation research, and the Bonazinga Award (1993) for Excellence in Leukocyte Biology Research presented by the Society for Leukocyte Research. Other honors include the Distinguished Alumni Achievement Award (1995) from the Downstate Medical Center of the State University of New York, the Washington College Distinguished Alumni Citation (1996), the Lifetime Achievement Award (1997) from the Arthritis Foundation, the Bravewell Leadership Award (2003) for outstanding achievements in the field of integrative medicine, the Leadership in Personalized Medicine Award (2007) from the Personalized Medicine Coalition, the Frost & Sullivan's North American HealthCare Lifetime Achievement Award (2008), the Triangle Business Journal's Healthcare Lifetime Achievement Award (2009), the David E. Rogers Award (2012) from the AAMC, and the North Carolina Life Sciences Leadership Award (2014). In bestowing Snyderman with the David E. Roger Award, the AAMC referred to Snyderman as the "father of personalized medicine." Snyderman also received an Honorary Doctor of Science degree (1996) from the Downstate Medical Center of the State University of New York and an honorary degree from Washington College in 2004 for outstanding achievement in the field of medicine.

Subject Headings

Preferred Citation

[identification of item], Ralph Snyderman (Personal) Papers, Duke University Medical Center Archives.

Acquisitions Information

Accession 2006.058 (gift, October 2006), Accession 2008.006 (gift, January 2008)

Processing Information

Processed by Alex Dowrey under the supervision of Lucy Waldrop: June 2017

Related Material

  • Ralph Snyderman (Chief) Papers
  • Ralph Snyderman Oral History Interviews